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Voorwoord 
Alles veroudert. De onderzoeksgroep waar ik voor dit proefschrift deel van uitmaakte, 
verdiept zich in het verouderingsproces van de mens. Het fascinerende – en tegelijkertijd 
ook lastige – is dat elk verouderingsproces uniek is. Het voorschrijven van een recept voor 
een goede oude dag kan dan ook als een uitdaging worden beschouwd. 
Het uitwisselen van wetenschappelijke kennis speelt een belangrijke rol in het steeds verder 
vergroten van het inzicht in dit verouderingsproces. Graag deel ik dan ook met u in de 
hierop volgende hoofdstukken de wetenschappelijke bevindingen die ik samen met mijn 
collega’s heb gedaan betreffende twee kenmerkende aspecten van veroudering: de 
cognitieve en fysieke veroudering. Beide zijn bepalend voor de zelfredzaamheid van 
ouderen en daarmee voor de kwaliteit van leven. 
Mijn dank gaat uit naar iedereen die heeft bijgedragen aan de totstandkoming van dit 
proefschrift: de deelnemers van de verschillende studies, mijn promotoren en co-promotor 
Eline Slagboom, Andrea Maier en Carel Meskers, collega’s, vrienden en familie. Jullie 
enthousiasme, betrokkenheid en steun hebben mij als mens en wetenschapper verrijkt. 
Daarbij wil ik ook waarde collega’s Robert Wagenaar en Ton de Craen noemen, opdat 
jullie bijdrage – in de stilte die is ontstaan – een blijvende herinnering zal zijn. 
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Introduction 
Decline in cognitive and physical performance are striking characteristics of the ageing 
process. Declining performances are already observed from the third decade of life with a 
steeper decline from the sixth decade of life1,2. Both cognitive and physical performance are 
important indicators of quality of life, strongly determining functional abilities and with 
that the ability to live independently3,4. With increasing life expectancy, the number of 
elderly people with impaired cognitive and physical performance will grow rapidly, putting 
a high demand on health care resources5. Understanding the age-related changes in 
cognitive and physical performance and most importantly their interactions is required for 
the development of preventive and therapeutic paradigms. 
However, the temporal order in which age-related changes in cognitive and physical 
performance occur is still largely unknown; it is unclear whether decline in cognitive 
performance precedes decline in physical performance, whether this temporal relationship 
is the other way around or whether they occur at the same time. Current literature is 
inconclusive showing uni- as well as bidirectional relationships between cognitive and 
physical performance6-9. Differences in findings between studies using different measures 
of cognitive and physical performance, i.e. global measures representing functioning on 
several cognitive or physical domains and domain specific measures, suggest dependence 
of the temporal relationship on these aspects9. Furthermore, it has become more and more 
evident in recent years that study findings might differ across different age ranges, 
especially for older populations aged 75 and over10,11. Unfortunately, studies are lacking 
assessing the temporal relationship between cognitive and physical performance across 
different age ranges and including various global and domain specific measures. Therefore, 
important indicators for an effective clinical assessment, development and application of 
(already existing) interventions are missing as well. 
Insights into the interactions between cognitive and physical performance might be 
suggestive for potential causal mechanisms. The temporal order of the interaction between 
cognitive and physical performance might indicate whether cognitive and physical 
performance are in each other’s causal pathway or whether their decline has common 
underlying causes. Such common causes may be illustrated by previous studies showing a 
potential role for brain pathology or a role for biological aspects of ageing such as increases 
in the number of senescent cells, i.e. cells with a permanently arrested cell cycle, or the 
decline of metabolic control12-15. These aspects have been shown to be important indicators 
of biological age reflecting the ageing rate of an individual, which may deviate from its 
calendar age. However, the association of biological age with cognitive and physical 
performance is still unknown and with that the potential insight this might give in the 
ageing process. 
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For the assessment of physical performance, instrumented measures are increasingly 
introduced in research and clinical settings to obtain a more refined observation of the 
individual16,17. These instrumented measures, obtained by e.g. camera-based systems, force 
plates or body fixed sensors, have been proven to be useful for the early identification and 
prediction of pathology such as Parkinson’s Disease16,18. The additional value of these 
measures for identification of age-related changes in physical performance and 
understanding of underlying determinants has not been established. 
Aim of this thesis 
The aim of this thesis was to enhance our understanding of age-related changes in cognitive 
and physical performance and their interactions. We focused on global and domain specific 
measures of cognitive and physical performance and assessed the interactions across 
different groups of calendar and biological age by including four study populations. 
Furthermore, instrumented measures of physical performance were introduced to assess 
their potential additional value. 
Study populations 
The Leiden Longevity Study 
The Leiden Longevity Study (LLS) is a longitudinal cohort of families of at least two long-
lived Caucasian siblings of Dutch descent fulfilling the age-criterion of 89 years or older 
for males and 91 years or older for females19. In this thesis, we used the middle-aged to 
older population of offspring of these nonagenarian siblings (n=500, mean age (standard 
deviation) 66 (6) years), who are enriched for familial factors of longevity, together with 
their partners as controls of similar age and sharing the same environmental conditions. 
Cross-sectional data was available on the cognitive domains of memory and executive 
function and the physical domains of standing balance, sit-to-stand transfers and walking 
across a 4-meter walk starting from standing position and across a steady-state 25-meter 
walk, i.e. without an acceleration or deceleration phase, both at usual pace. Thereby, a body 
fixed sensor positioned at the lower back was used during the performance of each of these 
physical tasks. This study population was especially used to get more insight into the 
sensitivity of different cognitive and physical domains to both calendar age and biological 
age, by comparing offspring of nonagenarian siblings with their partners, and assessing the 
associations with brain pathology. 
The Longitudinal Aging Study Amsterdam 
The Longitudinal Aging Study Amsterdam (LASA) consists of a random sample of middle-
aged to older adults (n=3107, mean age (standard deviation) 71 (9) years) drawn from the 
population registers of eleven municipalities in three culturally distinct geographical areas 
in the Netherlands20. Four repeated measurements on cognitive and physical performance 
assessed with a time interval of approximately three years were used. Besides domain 
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specific measures of memory and executive function, global cognitive function was 
assessed covering several domains like orientation, memory, attention and executive 
function. Physical domains included handgrip strength used as measure of overall muscle 
strength and walking speed across a 6-meter walk starting from standing position at 
maximal pace. This longitudinal study was used to assess the temporal relationship between 
global and domain specific measures of cognitive and physical performance across different 
age groups by stratification of the study population. 
The Leiden 85-plus Study 
The Leiden 85-plus Study includes inhabitants of the city of Leiden, the Netherlands, who 
all reached the age of 85 years (n=599) and were followed up yearly until the age of 90 
years21. Global and domain specific measures of cognitive and physical performance that 
were used were similar to those included in LASA: global cognitive function and memory 
and executive function, handgrip strength and walking speed. This study population was 
added to the analyses on the temporal relationship between cognitive and physical 
performance in LASA, resulting together in an age range from 55 to 90 years. 
Elderly outpatients 
The cross-sectional study of elderly outpatients consists of community-dwelling elderly 
(n=299, mean age (standard deviation) 82 (7) years) referred to the geriatric outpatient 
clinic of a middle-sized teaching hospital (Bronovo Hospital, The Hague, The Netherlands) 
for a comprehensive geriatric assessment. This assessment included global and domain 
specific measures of cognitive and physical performance: global cognitive function, 
standing balance and walking speed across a 4-meter and 6-minute walk starting from 
standing position and a steady-state 10-meter walk, all at usual pace. Additional to the other 
three study populations, this particular population was used to assess the cross-sectional 
association between different cognitive and physical domains in a clinically relevant 
population giving insight into the possible influence of health status or biological age on 
this relationship.  
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Outline 
Chapters two and three describe the sensitivity of domain specific measures of cognitive 
and physical performance to calendar and biological age assessed among the offspring of 
nonagenarian siblings and their partners of the LLS. In chapter four, the cross-sectional 
relationship between the cognitive and physical domains assessed in the LLS is presented 
and the influence of brain pathology on these domains as potential common underlying 
determinant. Chapters five and six focus on the cross-sectional relationship between 
different cognitive and physical domains in elderly outpatients. Chapter seven describes 
the temporal relationship between global and domain specific measures of cognitive and 
physical performance across different age groups of LASA and the Leiden 85-plus Study. 
Finally, in chapter eight, the main findings are summarized and discussed with a reflection 
on the clinical implications and future research.  
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Abstract 
Background: Decline in cognitive performance is a highly prevalent health condition in 
elderly. We studied whether offspring of nonagenarian siblings with a familial history of 
longevity, perform better on cognitive tests compared to their partners as controls. This is 
relevant since it could provide insights into determinants underlying decline in cognitive 
performance.  
Methods: Cross-sectional analysis within the longitudinal cohort of the Leiden Longevity 
Study consisting of middle-aged offspring of nonagenarian siblings together with their 
partners (n=500, mean age (SD) 66.3 (6.1) and 65.7 (7.2) years, respectively) as controls. 
Memory function, attention and processing speed were tested using the 15-Picture Learning 
Test, Stroop test and Digit Symbol Substitution Test. Data were analyzed with regression 
adjusted for age, gender, years of education and additionally for diabetes mellitus, 
cardiovascular diseases, alcohol use, smoking, inflammatory markers and apolipoprotein E 
genotype. Robust standard errors were used to account for familial relationships among the 
offspring. 
Results: Cognitive performance was worse at higher calendar age (p<0.001, all except 
Stroop test part 1). The offspring performed better compared to their partners on trial 3 
(p=0.005), the immediate (p=0.016) and delayed (p=0.004) recall of the 15-Picture 
Learning Test as well as on the interference and combined interference score of the Stroop 
test (p=0.014 and p=0.036, respectively) in the fully adjusted model. The difference 
between offspring and partners was estimated to be more than three years according to the 
observed difference in calendar age. 
Conclusions: Offspring of nonagenarian siblings with a familial history of longevity have 
better cognitive performance compared to the group of their partners of comparable age. 
This effect is independent of age-related diseases and known possible confounders. 
Possible explanations might be differences in subclinical vascular pathology between both 
groups.  
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Introduction 
Decline in cognitive performance is one of the most striking characteristics of the ageing 
process, already evident in middle age1-3 and for some cognitive domains, like processing 
speed and spatial visualization, even at the age of 20 to 30 years4. With increasing life 
expectancy, the number of elderly people with severe cognitive impairment will grow 
rapidly, leading to a high demand on our health care. Understanding of decline in cognitive 
performance will therefore be one of the challenges of this century in order to be able to 
develop interventions focused on maintenance of cognitive performance with age. 
Several causes and risk factors of decline in cognitive performance have been identified. 
Vascular pathology as well as cardiovascular risk factors, like alcohol use, smoking, 
hypertension and diabetes mellitus have been shown to play a prominent role in the 
development of cognitive decline5-10. Furthermore, decline in cognitive performance is 
associated with high systemic levels of inflammatory markers, such as C-reactive protein 
(CRP) and interleukin-6 (IL-6)8,11,12. Low socioeconomic status (including education, 
occupation and financial conditions) has been reported as predictor of cognitive decline13-15. 
The most important genetic risk factor for decline in cognitive performance is the 
apolipoprotein E (APOE) gene. Carriers of the APOE ε4 allele are at an increased risk of 
dementia, whereas carriers of the APOE ε2 allele might be protected16,17. 
In the Leiden Longevity Study, we have previously demonstrated that middle-aged 
offspring of nonagenarian siblings with a familial history of longevity have a lower 
prevalence of age-related diseases, like myocardial infarction, hypertension and type II 
diabetes, compared to their partners sharing the same environmental conditions18. Major 
indicators of lifestyle however, i.e. body mass index, current smoking and level of 
education, are not different between both groups18. These results suggest that the biological 
age, which means a person’s rate of ageing compared to their calendar age19,20, of the 
offspring of nonagenarian siblings is lower compared to their partners. Based on this 
assumption, we studied whether the offspring of nonagenarian siblings perform better on 
cognitive tests than their partners. 
Methods 
Ethics statement 
Ethics approval was provided through the Medical Ethical Committee of the Leiden 
University Medical Center. Written informed consent was obtained from all subjects. 
The Leiden Longevity Study 
The Leiden Longevity Study is a longitudinal cohort consisting of 421 families of long-
lived Caucasian siblings of Dutch descent together with their offspring and the partners 
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thereof21. The partners of the offspring were included as controls being of comparable age 
and sharing the same socioeconomic and geographical background as the offspring. 
Families were recruited if at least two long-lived siblings were alive and fulfilled the age-
criterion of 89 years for males and 91 years for females. Sex-specific age-criteria were used 
due to the higher life-expectancy of females compared to males18,21. No selection criteria on 
health or demographic characteristics were applied. Recruitment took place between July 
2002 and May 2006 and the families are followed up since that time. Cognitive 
performance was tested in a random subgroup of subjects (250 offspring and 250 partners 
thereof) during a visit at the research center between September 2009 and December 2010. 
Cognitive performance 
The primary outcome was cognitive performance, which was tested for different cognitive 
domains like memory function, attention and processing speed. Memory function was 
assessed by the 15-Picture Learning Test (15-PLT). Subjects were shown 15 pictures of 
well-known items and then asked to recall as many as possible. The test was repeated three 
consecutive times and after 20 minutes. Outcome parameters were the number of correct 
pictures after each trial and after 20 minutes (delayed recall). The total number of correct 
answers after three trials was defined as the immediate recall. Furthermore, the number of 
incorrect pictures was reported for each trial. Attention and processing speed were assessed 
by the Stroop test and the Digit Symbol Substitution Test (DSST). The Stroop test 
consisted of three parts in which the subject had to name 40 items shown on a card. In part 
1, the subjects were instructed to read color words, which were printed in black on card 1. 
In part 2, the card contained colored blocks and the subjects were asked to name the printed 
colors. In part 3, the card again contained color words, however printed in a discongruous 
ink color. The subjects were asked to name the ink color of the words. During all parts, the 
subjects were encouraged to read the card as fast as possible. The time needed to process 
each of the different parts as well as the errors during each trial were used as outcome 
parameters. Furthermore, the interfering effect of words upon the naming of colors 
(interference score) was assessed by calculating the difference in time needed for part 3 and 
222. A combined interference score was calculated, in which both outcome parameters, time 
and number of errors, were combined. For each uncorrected error twice the average time 
per word for reading the card on which the error was made was added to the time needed to 
finish the card22. In the DSST, digits were presented and the subjects were asked to write 
the corresponding symbols in a blank space according to a given key. Outcome parameter 
was the number of correct digit-symbol combinations within 90 seconds. The DSST was 
added to the protocol later resulting in available data for 446 of the 500 subjects (223 
offspring and 223 partners).  
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Potential confounders 
Total number of years of education was calculated for each subject, based on self-reported 
information about the highest completed level of education. Conversion from highest 
educational level to total number of years of education was based on the Dutch educational 
system. Information on medical history was requested from the subjects’ treating physician 
including diabetes mellitus and cardiovascular diseases, defined as myocardial infarction, 
stroke and hypertension18. Information was obtained from 440 of the 500 subjects from the 
treating physicians. Questionnaires were used to obtain information about alcohol use and 
smoking. Inflammatory markers, i.e. high-sensitivity (hs) CRP and IL-6, were available in 
non-fasting serum samples for 480 of the 500 subjects at baseline. In 20 subjects non-
fasting serum samples were not available due to technical problems or refusal of the 
subject. For hsCRP, the Hitachi Modular P 800 from Roche, Almere, the Netherlands was 
used23. IL-6 levels were determined with the Pelikine Compact human IL-6 ELISA kit from 
Sanquin reagents, Amsterdam, the Netherlands. APOE genotypes were determined within a 
genome-wide association study24. Three groups were defined for the statistical analysis 
including homozygotes of the APOE ε3 allele (ε3ε3), carriers of the APOE ε2 allele (ε2ε2 
and ε2ε3) and carriers of the APOE ε4 allele (ε4ε4, ε3ε4, ε2ε4). 
Statistical analysis 
A cross-sectional analysis was performed to assess the association of cognitive performance 
with calendar age as well as with familial longevity in 250 offspring and 250 partners of the 
Leiden Longevity Study. 
First, the association between calendar age and cognitive performance was assessed using 
linear regression analysis. Two different models were applied. In model 1, the analysis was 
adjusted for gender and years of education. Model 2 was as model 1 with further 
adjustments for comorbidities, alcohol use, smoking, inflammatory markers and APOE 
genotype. Subjects with hsCRP levels higher than 30 mg/L (n=4) or IL-6 levels higher than 
10 pg/mL (n=2) were excluded from the analysis in model 2 in order to exclude possible 
influences of acute inflammatory conditions. Logistic regression was applied to assess the 
association between calendar age and the dichotomized number of mistakes reported for the 
15-PLT and the Stroop test, i.e. one group with subjects having no mistakes and one group 
with subjects having one or more mistakes. The same two models described above were 
used for the logistic regression analysis. 
Second, linear regression analysis was used to investigate the association between familial 
longevity (offspring versus partner status) and cognitive performance. Logistic regression 
analysis was used for the association between familial longevity and the two groups of 
subjects with and without mistakes for the 15-PLT and Stroop test. Again, two different 
models were applied. Model 1 included age, gender and years of education. Model 2 was as 
model 1 with further adjustments for comorbidities, alcohol use, smoking, inflammatory 
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markers and APOE genotype. All p-values for differences between offspring and partners 
were adjusted for familial relationships among the offspring using robust standard errors. 
Finally, a sensitivity analysis was performed excluding the subjects with the APOE ε2ε4 
genotype for both the analysis with calendar age and familial longevity. This subgroup was 
excluded because they have both the allele for an increased and decreased risk of dementia 
and could therefore attenuate the influence of APOE genotype on the results. Furthermore, 
the difference in cognitive performance between offspring and partners was expressed in 
years according to calendar age. For this calculation, the difference in cognitive 
performance between offspring and partners was divided by the difference in cognitive 
performance with calendar age per year of the fully adjusted model. 
All statistical analyses were performed with Stata (version 12.0 for Windows, USA) and 
SPSS (version 20.0 for Windows, USA). P-values <0.05 were considered statistically 
significant. 
Results 
Table 1 shows the characteristics of the study population. Offspring and partners had 
similar age and years of education. The prevalence of age-related diseases, like diabetes 
mellitus and hypertension, was lower among the offspring compared to their partners. 
Table 2 and 3 present the association between calendar age and cognitive performance. 
Overall, higher calendar age was associated with worse cognitive performance. The 
association between calendar age and cognitive performance remained statistically 
significant after adjustment for known possible confounders, except for the Stroop test part 
1 (Table 2). The number of subjects with mistakes was higher at higher calendar age for the 
Stroop test part 3. No association with calendar age was found for the Stroop test part 2 and 
the 15-PLT (Table 3). Sensitivity analysis excluding the subjects with the APOE ε2ε4 
genotype did not change the results. 
Table 4 and 5 show the association of familial longevity and cognitive performance, 
comparing offspring of nonagenarian siblings with a familial history of longevity with their 
partners. In the fully adjusted model, the offspring performed better compared to their 
partners on part 3, the immediate and delayed recall of the 15-PLT as well as on the 
(combined) interference score of the Stroop test (Table 4). The number of subjects with 
mistakes reported for the 15-PLT was not different between offspring and partners. Among 
the offspring, the number of subjects with mistakes was lower for the Stroop test part 2 and 
3 compared to their partners. After adjustment for possible confounders, the association 
remained statistically significant for the Stroop test part 3 (Table 5). Sensitivity analysis 
excluding the subjects with the APOE ε2ε4 genotype did not change the results. 
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Table 1. Characteristics 
 Offspring (N=250) Partners (N=250) 
Demographics   
Females, n (%) 114 (45.6) 139 (55.6) 
Age, years 66.3 (6.1) 65.7 (7.2) 
Years of education, median (IQR) 12 (10 - 15) 12 (10 - 15) 
Anthropometrics   
Height, cm 172.5 (8.9) 171.6 (8.8) 
Weight, kg 78.7 (13.4) 79.2 (13.7) 
Comorbidities*, n (%)   
Diabetes mellitus 7 (3.2) 20 (9.1) 
Myocardial infarction 4 (1.8) 8 (3.6) 
Stroke 5 (2.2) 5 (2.3) 
Hypertension 56 (25.7) 66 (30.6) 
COPD 13 (5.9) 9 (4.1) 
Malignancy 13 (5.9) 21 (9.6) 
Rheumatoid arthritis 2 (0.9) 3 (1.4) 
Intoxications, n (%)   
Users of alcohol† 192 (78.0) 194 (78.5) 
Former and/or current smokers 158 (64.2) 185 (74.9) 
Inflammatory markers‡, median (IQR)   
hsCRP, mg/L  1.2 (0.65 - 2.49) 1.4 (0.71 - 2.87) 
IL-6, pg/mL 0.30 (0.11 - 0.65) 0.36 (0.13 - 0.62) 
APOE genotype, n (%)   
ε2ε2 2 (0.8) 1 (0.4) 
ε2ε3 27 (11.1) 21 (8.4) 
ε2ε4 11 (4.5) 10 (4.0) 
ε3ε3 151 (60.4) 166 (66.7) 
ε3ε4 51 (20.4) 47 (18.9) 
ε4ε4 2 (0.8) 4 (1.6) 
Values are expressed as mean (standard deviation), unless otherwise indicated. Abbreviations: IQR, interquartile 
range; COPD, chronic obstructive pulmonary disease; hsCRP, high-sensitivity C-reactive protein; IL-6, 
interleukin-6; APOE, apolipoprotein E. *n=220 for offspring and n=220 for partners. †Using ≥1 units per week. 
‡n=240 for offspring and n=240 for partners. 
Figure 1 and 2 show the estimated mean values of the 15-PLT and Stroop test, respectively, 
stratified for tertiles of calendar age (upper panel) and stratified for offspring and partners 
(lower panel). Preservation of cognitive performance of offspring compared to partners was 
estimated to be more than three years based on the difference in cognitive performance with 
calendar age per year in trial 3, the immediate and delayed recall of the 15-PLT as well as 
in the (combined) interference score of the Stroop test. The delayed recall of the 15-PLT 
showed the largest difference, with an estimated preservation of cognitive performance of 
the offspring of more than seven years.  
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Table 2 Cognitive performance dependent on calendar age in years. 
Cognitive All subjects*  Model 1  Model 2 
performance tests N=500  β 95% CI p  β 95% CI p 
15-PLT, # pictures          
trial 1  7.4 (0.08)  -0.06 -0.08, -0.04 <0.001  -0.07 -0.10, -0.04 <0.001 
trial 2  10.4 (0.09)  -0.09 -0.12, -0.06 <0.001  -0.11 -0.14, -0.08 <0.001 
trial 3  12.0 (0.09)  -0.08 -0.10, -0.06 <0.001  -0.08 -0.11, -0.06 <0.001 
immediate recall 29.7 (0.23)  -0.23 -0.29, -0.17 <0.001  -0.26 -0.33, -0.19 <0.001 
delayed recall 11.2 (0.10)  -0.07 -0.10, -0.05 <0.001  -0.08 -0.11, -0.05 <0.001 
Stroop test, s          
part 1 20.3 (0.26)  0.08 0.01, 0.16 0.036  0.08 -0.01, 0.16 0.081 
part 2 24.8 (0.23)  0.18 0.11, 0.24 <0.001  0.18 0.10, 0.25 <0.001 
part 3 49.4 (0.65)  0.83 0.65, 1.00 <0.001  0.89 0.69, 1.08 <0.001 
Interference score 24.6 (0.56)  0.65 0.50, 0.81 <0.001  0.71 0.54, 0.89 <0.001 
Comb. int. score 26.3 (0.69)  0.79 0.60, 0.98 <0.001  0.85 0.64, 1.07 <0.001 
DSST†, # answers 46.2 (0.51)  -0.71 -0.84, -0.58 <0.001  -0.67 -0.82, -0.52 <0.001 
*Values are expressed as mean (standard error). †N=446. Abbreviations: β, estimate; CI, confidence interval; 15-
PLT, 15-Picture Learning Test; #, number; comb. int., combined interference; DSST, Digit Symbol Substitution 
Test. Model 1: adjusted for gender and years of education. Model 2: as model 1 + diabetes mellitus, cardiovascular 
diseases (myocardial infarction, stroke and hypertension), alcohol use, smoking, high-sensitivity C-reactive 
protein, interleukin-6 and apolipoprotein E genotype. 
Table 3 Cognitive performance expressed as number of subjects with mistakes dependent on calendar age in years. 
Cognitive All subjects*  Model 1  Model 2 
performance tests N=500  OR 95% CI p  OR 95% CI p 
15-PLT†          
trial 1  28 (5.6)  1.00 0.95, 1.07 0.90  1.01 0.94, 1.09 0.74 
trial 2  28 (5.6)  1.00 0.94, 1.06 0.88  1.01 0.94, 1.08 0.76 
trial 3  20 (4.0)  0.99 0.92, 1.06 0.78  1.00 0.92, 1.09 0.97 
immediate recall 47 (9.4)  1.00 0.96, 1.05 0.89  1.01 0.96, 1.07 0.71 
delayed recall 35 (7.1)  0.98 0.93, 1.04 0.50  1.00 0.94, 1.06 0.96 
Stroop test†          
part 2 36 (7.2)  1.05 0.99, 1.11 0.081  1.04 0.98, 1.11 0.22 
part 3 134 (27.0)  1.09 1.05, 1.13 <0.001  1.10 1.06, 1.15 <0.001 
*Values are expressed as number (%). †Subjects with no mistakes = 0, subjects with one or more mistakes = 1. 
Abbreviations: OR, odds ratio; CI, confidence interval; 15-PLT, 15-Picture Learning Test. Model 1: adjusted for 
gender and years of education. Model 2: as model 1 + diabetes mellitus, cardiovascular diseases (myocardial 
infarction, stroke and hypertension), alcohol use, smoking, high-sensitivity C-reactive protein, interleukin-6 and 
apolipoprotein E genotype.  
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Table 4 Cognitive performance dependent on familial longevity (offspring versus partner status*). 
Cognitive Offspring†  Partners† Model 1 Model 2 
performance tests N=250  N=250 β 95% CI p β 95% CI p 
15-PLT, # pictures          
trial 1  7.4 (0.11)  7.4 (0.12) -0.13 -0.44, 0.18 0.40 -0.28 -0.63, 0.07 0.11 
trial 2  10.4 (0.13)  10.3 (0.14) -0.23 -0.56, 0.10 0.17 -0.30 -0.67, 0.07 0.11 
trial 3  12.1 (0.12)  11.9 (0.12) -0.32 -0.63, -0.01 0.042 -0.47 -0.80, -0.15 0.005 
immediate recall 29.9 (0.31)  29.6 (0.33) -0.69 -1.48, 0.10 0.088 -1.06 -1.92, -0.19 0.016 
delayed recall 11.3 (0.14)  11.1 (0.14) -0.42 -0.77, -0.07 0.020 -0.58 -0.98, -0.18 0.004 
Stroop test, s          
part 1 20.9 (0.38)  19.7 (0.34) -1.27 -2.31, -0.23 0.017 -0.91 -2.13, 0.32 0.15 
part 2 25.3 (0.33)  24.4 (0.30) -0.86 -1.74, 0.02 0.057 -0.75 -1.77, 0.27 0.15 
part 3 48.8 (0.86)  50.0 (0.97) 1.62 -0.67, 3.91 0.17 2.02 -0.56, 4.61 0.13 
Interference score 23.5 (0.74)  25.7 (0.84) 2.52 0.50, 4.54 0.015 2.84 0.57, 5.10 0.014 
Comb. int. score 25.1 (0.92)  27.5 (1.02) 2.80 0.30, 5.30 0.028 3.12 0.21, 6.03 0.036 
DSST‡, # answers 46.3 (0.71)  46.2 (0.74) -0.32 -2.16, 1.52 0.73 -0.82 -2.86, 1.21 0.43 
*Offspring = 0, partner = 1. †Values are expressed as mean (standard error). ‡n=223 for offspring and n=223 for 
partners. Abbreviations: β, estimate; CI, confidence interval; 15-PLT, 15-Picture Learning Test; #, number; comb. 
int., combined interference; DSST, Digit Symbol Substitution Test. Model 1: adjusted for age, gender and years of 
education. Model 2: as model 1 + diabetes mellitus, cardiovascular diseases (myocardial infarction, stroke and 
hypertension), alcohol use, smoking, high-sensitivity C-reactive protein, interleukin-6 and apolipoprotein E 
genotype. Robust standard errors were used to account for familial relationships among the offspring. 
Table 5 Cognitive performance expressed as number of subjects with mistakes dependent on familial longevity 
(offspring versus partner status*). 
Cognitive Offspring†  Partners† Model 1 Model 2 
performance tests N=250  N=250 OR 95% CI p OR 95% CI p 
15-PLT‡          
trial 1  13 (5.2)  15 (6.0) 1.13 0.53, 2.44 0.75 1.33 0.48, 3.68 0.58 
trial 2  15 (6.0)  13 (5.2) 0.89 0.41, 1.94 0.77 0.95 0.37, 2.45 0.92 
trial 3  10 (4.0)  10 (4.0) 1.09 0.44, 2.71 0.85 0.81 0.29, 2.28 0.69 
immediate recall 24 (9.6)  23 (9.2) 0.94 0.51, 1.73 0.85 0.88 0.43, 1.82 0.74 
delayed recall 16 (6.4)  19 (7.7) 1.32 0.63, 2.76 0.47 1.28 0.55, 2.99 0.57 
Stroop test‡          
part 2 12 (4.8)  24 (9.6) 2.10 1.02, 4.32 0.043 2.03 0.86, 4.82 0.11 
part 3 56 (22.6)  78 (31.3) 1.64 1.08, 2.50 0.021 1.69 1.05, 2.70 0.029 
*Offspring = 0, partner = 1. †Values are expressed as number (%). ‡Subjects with no mistakes = 0, subjects with 
one or more mistakes = 1. Abbreviations: OR, odds ratio; CI, confidence interval; 15-PLT, 15-Picture Learning 
Test. Model 1: adjusted for age, gender and years of education. Model 2: as model 1 + diabetes mellitus, 
cardiovascular diseases (myocardial infarction, stroke and hypertension), alcohol use, smoking, high-sensitivity C-
reactive protein, interleukin-6 and apolipoprotein E genotype. Robust standard errors were used to account for 
familial relationships among the offspring.  
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Figure 1 Association of the 15-Picture Learning Test with calendar age and familial longevity. In the upper and 
lower panel, estimated mean values for trial 3, the immediate (PLTi) and delayed (PLTd) recall of the 15-Picture 
Learning Test are shown in tertiles of calendar age and for offspring versus partner status, respectively. Error bars 
indicate standard error. Analyses on calendar age are adjusted for gender, years of education, diabetes mellitus, 
cardiovascular diseases, alcohol use, smoking, high-sensitivity C-reactive protein, interleukin-6 and 
apolipoprotein E genotype. P-values indicate p for trend. Analyses on offspring versus partner status are adjusted 
additionally for age and for familial relationships among the offspring using robust standard errors. P-values 
indicate the difference between offspring and partners. 
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Figure 2 Association of the Stroop test with calendar age and familial longevity. In the upper and lower panel, 
estimated mean values for part 3, the interference score and combined interference score of the Stroop test are 
shown in tertiles of calendar age and for offspring versus partner status, respectively. Error bars indicate standard 
error. Analyses on calendar age are adjusted for gender, years of education, diabetes mellitus, cardiovascular 
diseases, alcohol use, smoking, high-sensitivity C-reactive protein, interleukin-6 and apolipoprotein E genotype. 
P-values indicate p for trend. Analyses on offspring versus partner status are adjusted additionally for age and for 
familial relationships among the offspring using robust standard errors. P-values indicate the difference between 
offspring and partners. Take note that lower Stroop scores indicate better cognitive performance. 
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Discussion 
The aim of this study was to compare cognitive performance between middle-aged 
offspring of nonagenarian siblings with a familial history of longevity and the group of 
their partners of comparable age and sharing the same environmental conditions. Cognitive 
performance was better among the offspring compared to their partners, even after 
adjustment for known possible confounders. Furthermore, higher calendar age was 
associated with worse cognitive performance. According to calendar age, the preservation 
of cognitive performance of the offspring compared to their partners was estimated to be 
more than three years. 
Despite the relative small age range and relatively good health status of the subjects of the 
Leiden Longevity Study, a significant association between calendar age and cognitive 
performance was found. Adjustment for possible risk factors for cognitive decline, such as 
diabetes mellitus, cardiovascular diseases, alcohol use, smoking, systemic inflammation 
and APOE genotype did not change the results. The association between calendar age and 
cognitive performance was found in all cognitive domains that were tested, i.e. memory 
function, attention and processing speed. This makes it likely that processes during the 
ageing course play a prominent role in the development of decline in cognitive performance 
even from middle age1-3. 
Cognitive performance was better among the offspring of nonagenarian siblings compared 
to their partners, with whom they share their life. The difference in cognitive performance 
between offspring and partners remained statistically significant after adjustment for 
possible confounders8-10. This indicates that the difference in cognitive performance 
between offspring and partners cannot be accounted for by diabetes mellitus, cardiovascular 
diseases, alcohol use and smoking. Neither changed the results after adjustment for 
inflammatory markers, of which high systemic levels have been reported to be associated 
with decline in cognitive performance as well8,11,12. Furthermore, the association of 
cognitive performance with familial longevity remained statistically significant after 
adjustment for APOE genotype. The APOE genotype is besides one of the most important 
genetic risk factors for cognitive decline16,17, consistently shown to be associated with 
survival and longevity25,26. A genome wide association study performed in the 
nonagenarian participants of the Leiden Longevity Study identified the APOE ε4 isoform as 
deleterious to longevity, which was confirmed in a meta-analysis of three different 
replication cohorts24. Adjustment for familial relationships among the offspring did not 
change the results either, which excludes the influence of familial resemblance on the 
difference between offspring and partners in cognitive performance. 
Altogether, the independence of the difference in cognitive performance between offspring 
and partners of above mentioned risk factors, suggests that the results have to be explained 
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by other factors. One possible explanation is that the offspring are biologically younger 
compared to their partners, which means that the person’s rate of ageing of the offspring is 
slower compared to their partners. Based on the effect sizes of the association of cognitive 
performance with calendar age and familial longevity, the preservation of cognitive 
performance of the offspring was estimated to be more than three years according to 
calendar age. This finding of the offspring being biologically younger compared to their 
partners is in line with several other observations. The younger biological age of the 
offspring is reflected by their lower mortality rate, beneficial glucose and lipid metabolism, 
preservation of insulin sensitivity, preservation of naïve T-cell pool and resistance to 
cellular stress18,21,27-29. 
Another possible explanation is that the offspring have a better health status compared to 
their partners due to a more favorable development in utero or during early childhood. This 
explanation might be supported by the fact that the differences between offspring and 
partners in cognitive performance are already visible at middle age, when decline in 
cognitive performance is relatively small. However, data to test this possible explanation 
are currently not available and would require a familial multigenerational design. 
Very recently we found differences in subclinical vascular pathology between offspring and 
partners. Assessment of magnetic resonance imaging scans in a subgroup of offspring and 
partners showed that the offspring had a lower periventricular as well as subcortical white 
matter load and a lower prevalence of lacunar infarcts compared to their partners30. Further 
research on the relation between the differences in subclinical vascular pathology and 
cognitive performance among the offspring and their partners is needed to get more insight 
into this possible causal pathway. 
One of the strengths of our study is the unique study design of comparing middle-aged 
individuals, who are enriched for familial factors of longevity, to their partners. This gives 
the possibility to get more insight into determinants of healthy longevity. By including 
couples, the influence of socioeconomic status was relatively low making the groups highly 
comparable. The relative young age of the subjects is both a strength and limitation of the 
study. Differences in cognitive performance with calendar age in this relatively young study 
population were already observable; however, differences between offspring and partners 
may therefore be underestimated. Another limitation is the cross-sectional design of the 
present analysis, as cognitive performance data became available just recently. 
In conclusion, offspring of nonagenarian siblings with a familial history of longevity 
showed a better cognitive performance compared to their partners being independent of 
known possible confounders. This makes it likely that cognitive performance is preserved 
with familial longevity. Further research on the possible causes of the relation between 
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cognitive performance and familial longevity is needed in order to be able to get a better 
understanding of preservation of cognitive performance with age. 
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Abstract 
Background: Decline in physical performance is highly prevalent during ageing. 
Identification of sensitive markers of age-related changes in physical performance is 
important for early detection, development of therapeutic strategies and insight into 
underlying mechanisms. We studied the association of calendar age and familial longevity 
with standard clinical and instrumented measures of physical performance in a cohort of 
healthy middle-aged to older adults. 
Methods: Cross-sectional analysis within the Leiden Longevity Study consisting of 
offspring of nonagenarian siblings and their partners (n=300, mean age (SD) 65.3 (6.7) 
years). Standard clinical measures were 25-meter walking speed and total duration of the 
chair stand test (CST). Instrumented measures were determined using a body fixed sensor. 
Dependence of physical performance on calendar age and familial longevity (offspring 
versus partner status) was analyzed using linear and logistic regression, respectively, 
adjusted for gender and height.  
Results: Higher calendar age was associated with slower walking speed and longer duration 
of the CST (standardized β (95% CI) -0.024 (-0.042;-0.006) and 0.035 (0.014;0.056), 
respectively). Instrumented measures showed similar effect sizes with strongest 
associations for gait stability and symmetry in mediolateral direction and for the extension 
and flexion phase of sit-to-stand and stand-to-sit transfers, respectively. No differences 
were observed between offspring of nonagenarian siblings and their partners. 
Conclusions: Standard clinical and instrumented measures of physical performance are 
associated with similar effect size to age-related changes in physical performance 
observable from middle age. The potential added value of instrumented measures for 
understanding underlying mechanisms requires further attention.  
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Introduction 
Decline in physical performance is highly prevalent during ageing leading to loss of 
independence and a poorer quality of life1. Furthermore, older adults with impaired 
physical performance have a high risk of falls, further reducing the quality of life and 
placing a heavy economic burden on society2. Identification of sensitive markers of age-
related changes in physical performance is of utmost importance for the early detection, 
development of therapeutic strategies and insight into underlying mechanisms. 
Assessment of physical performance is part of the comprehensive geriatric assessment 
(CGA) in clinical practice. Important clinical measures of physical performance commonly 
include walking speed and the duration of repeated sit-to-stand movements, assessed by the 
chair stand test (CST)3,4. Walking speed is an important indicator of health status and 
function by reflecting the interaction of several underlying systems, such as the central and 
peripheral nervous, sensory, muscular, skeletal, and cardiopulmonary system5,6. Sit-to-stand 
movements are one of the most mechanically demanding functional tasks during daily 
activities7. Furthermore, the CST is an important indicator for the performance of other 
daily activities, like climbing stairs, by measuring lower body strength8. 
Standard clinical measures of physical performance, using simply total time as the 
outcome, provide a common output representing a combination of possible underlying 
mechanisms. Based on previous studies showing the association of calendar age with 
various instrumented measures of physical performance and their use in the early 
identification and prediction of pathology9-11, instrumented measures might be sensitive 
markers of age-related changes in physical performance providing possible insights into 
underlying determinants. Therefore, we assessed the association of calendar age with 
standard clinical and instrumented measures of the 25-meter walk and CST in a study 
population of offspring of nonagenarian siblings together with their partners. We used this 
study population of middle-aged to older adults to be able to assess changes in physical 
performance that are already observable from middle age in the absence of overt diseases. 
Additionally, we compared both measures between the offspring of nonagenarian siblings, 
who are enriched for familial factors of longevity, and their partners to assess the sensitivity 
for familial longevity representing the biological age of the participants, i.e. the person’s 
rate of ageing compared to their calendar age. 
Methods 
The Leiden Longevity Study 
The Leiden Longevity Study is a longitudinal cohort consisting of 421 families of long-
lived Caucasian siblings of Dutch descent12. Families were recruited if at least two long-
lived siblings were alive and met the age criteria of ≥89 years for males and ≥91 years for 
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females. Additionally, the offspring of these long-lived families were included together 
with their partners as controls being of comparable age and sharing the same 
socioeconomic and geographical background. Enrolment took place between July 2002 and 
May 2006. Physical performance was assessed among a random subgroup of participants 
(n=300) between September 2009 and December 2010. All physical performance tests were 
performed in the Leiden University Medical Center by two research nurses. The Medical 
Ethical Committee of the Leiden University Medical Center approved the study and written 
informed consent was obtained from all participants. 
Instrumentation 
During the 25-meter walk and CST, a body fixed sensor (Dynaport® Hybrid, McRoberts 
BV, The Hague, The Netherlands) was inserted in an elastic belt and positioned on the 
lower back at the height of the second lumbar vertebra13. The sensor consisted of one 
triaxial accelerometer and three uniaxial gyroscopes with a sampling rate of 100 Hz. The 
start and end of each physical performance test was marked by the research nurse using a 
remote control. Participants wore non-slip socks during all physical performance tests. 
25-meter walk 
The 25-meter walk was performed twice in steady state over a length of 30 m, i.e. time 
started at 2.5 m and stopped at 27.5 m. Participants were asked to walk at their preferred 
speed. Gait characteristics were determined over the time interval of begin till end marker 
of the test. Walking speed was used as standard clinical measure and determined by 
dividing the distance of 25 m by the total duration of the test. Instrumented measures of gait 
performance were determined using a previously developed algorithm, of which the 
precision, reliability and validity has been shown in earlier studies14,15. Because of the 
relatively short distance of the 25-meter walk for determination of some gait characteristics, 
like stride-to-stride variability or local dynamic stability16, we used only those variables 
with an ICC ≥0.80 over two repeated measurements. This resulted in four different gait 
characteristics, i.e. gait kinematics, stability, symmetry and variability, which were 
included in the statistical analyses for each participant. Data were aligned to a common, 
body centered reference frame with axes in the vertical (VT), mediolateral (ML) and 
anterior-posterior (AP) direction. Thereby the VT direction was defined as the direction of 
the mean acceleration signal. Stride time was estimated as measure of gait kinematics. The 
standard deviation of the acceleration signal, defined as the movement intensity which is 
equivalent to the acceleration root mean square, was used as measure of gait stability. Gait 
symmetry was estimated by the harmonic ratio. The amplitude of the dominant frequency 
of the signal’s power spectral density within the frequency range of locomotion (0.5 – 3 
Hz) was used as measure for consistency and variability of gait. Gait stability, symmetry 
and variability were determined in VT, ML and AP direction. For each parameter, the mean 
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of the two measurements was used for analyses. Due to missing data, data was available for 
292 subjects (97%) (Figure 1). 
Chair stand test 
The ability to rise from a chair was tested by the CST. Participants were asked to stand up 
and sit down five times as quickly as possible from a straight-backed chair with default seat 
height. Total duration of the CST was used as standard clinical measure and determined by 
the time between begin and end marker of the test. Repeated sit-to-stand and stand-to-sit 
transfers were detected automatically by a commercially available algorithm of which the 
precision, validity and reliability has been shown previously in older adults11,13,17. Thereby, 
four main phases were distinguished; sit-to-stand, standing, sitting and stand-to-sit. The sit-
to-stand and stand-to-sit phases were distinguished further into a flexion and extension 
phase, according to flexion and extension of the lower back. For each repetition, the 
duration of the different phases was determined as well as the maximum angular velocity 
(in deg/s) of the flexion and extension phases. For each parameter of the four main phases, 
mean values of at least four repeated transfers were calculated and used for statistical 
analyses. Due to technical problems in the automated signal analysis, data on the CST was 
available for 221 (74%) participants (Figure 1), which was a random loss of participants. 
 
Figure 1 Flow chart of the study population with available data on the different physical performance tests. 
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Figure 2 Scatter plots with trend lines of standard clinical measures of the 25-meter walk and chair stand test, i.e. 




Continuous variables with Gaussian distribution are presented as mean and standard 
deviation, non-Gaussian distributed variables as median and interquartile range, and 
categorical variables as number and percentage. Linear and logistic regression analysis was 
used to assess the cross-sectional association between calendar age and physical 
performance and between familial longevity (offspring versus partner status) and physical 
performance, respectively. Results were adjusted for gender and height. In the analysis 
testing differences depending on familial longevity, results were adjusted additionally for 
calendar age and for familial relationships among the offspring using robust standard 
errors. 
All statistical analyses were performed with the normal values of physical performance 
(defined as unstandardized) and with the parameters of physical performance expressed as 
z-scores to enable the comparison of effect sizes. The relation between calendar age and 
standard clinical measures of physical performance were visualized by using scatter plots. 
The comparison of effect sizes was visualized by plotting the estimated mean (standard 
error) of the z-scores of the standard clinical and instrumented measures of the 25-meter 
walk and CST in tertiles of calendar age. For the instrumented measures of the 25-meter 
walk and CST, the parameters with the highest effect sizes for each of the gait 
characteristics, i.e. kinematics, stability, symmetry and variability, and for each phase of the 
CST were plotted. 
P values less than 0.05 were considered statistically significant. All statistical analyses were 
performed with SPSS version 20.0 (SPSS Inc., Chicago, USA) and Stata version 12.0 
(Stata, College Station, USA). Figures were made with GraphPad Prism 5 (GraphPad 
Software, Inc., La Jolla, USA). 
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Results 
The characteristics of the participants are shown in Table 1 together with the characteristics 
stratified for offspring and partners. Mean age (SD) of all participants was 65.3 (6.7) years. 
Offspring and partners had similar calendar age, years of education and measures of 
anthropometrics. The prevalence of age-related diseases, like diabetes mellitus and 
hypertension, was lower among offspring compared to their partners. In Figure 2, the 25-
meter walking speed and duration of the CST for all participants is plotted against calendar 
age. 
Table 2 presents the association between calendar age and physical performance. 
Participants with a higher calendar age had a slower walking speed and longer duration of 
the CST (standardized β (95% CI) -0.024 (-0.042;-0.006) and 0.035 (0.014;0.056), 
respectively). According to the instrumented measures of gait characteristics, i.e. gait 
kinematics, stability, symmetry and variability, a higher calendar age was associated with a 
longer stride time, lower movement intensity and harmonic ratio in ML and AP direction 
and a higher amplitude of the dominant frequency in VT direction. During the sit-to-stand 
phase of the CST, a higher calendar age was associated with a longer duration and slower  
Table 1 Characteristics of all participants and stratified by offspring of nonagenarian siblings and their partners. 
 All (N=300) Offspring (N=151) Partners (N=149) 
Demographics    
Females, n (%) 152 (50.7) 71 (47.0) 81 (54.4) 
Age, years 65.3 (6.7) 65.7 (6.1) 65.0 (7.3) 
Education, years* 12 (10 - 15) 12 (10 - 15) 12 (10 - 15) 
Anthropometrics    
Height, cm 172.4 (8.5) 172.4 (8.8) 172.4 (8.2) 
Weight, kg 79.3 (14.1) 78.5 (13.9) 80.1 (14.2) 
Comorbidities    
Diabetes Mellitus 18 (6.8) 4 (3.0) 14 (10.6) 
Myocardial infarction 8 (3.0) 3 (2.2) 5 (3.7) 
Stroke 8 (2.9) 3 (2.2) 5 (3.7) 
Hypertension 73 (27.1) 32 (23.4) 41 (31.1) 
COPD 9 (3.3) 5 (3.6) 4 (3.0) 
Malignancy 17 (6.3) 7 (5.1) 10 (7.6) 
Rheumatoid arthritis 4 (1.5) 2 (1.5) 2 (1.5) 
Intoxications    
Users of alcohol† 237 (79.3) 116 (77.3) 121 (81.2) 
Former and/or current smokers 203 (67.9) 94 (62.7) 109 (73.2) 
Values are expressed as mean (standard deviation), unless otherwise indicated. Abbreviations: n, number; COPD, 
Chronic Obstructive Pulmonary Disease. *Values are expressed as median (interquartile range). †Using ≥1 units 
per week.  
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Table 2 Physical performance dependent on calendar age in years presented unstandardized and expressed as z-
score. 
  Unstandardized Expressed as z-score  
 All subjects β 95% CI β 95% CI p 
25-meter Walk‡       
Standard measure       
Walking speed, m/s 1.45 (.009) -.004 -.007;-.001 -.024 -.042;-.006 .008 
Gait kinematics       
Stride time, s .98 (.004) .001 .000;.002 .017 .001;.033 .041 
Gait stability       
Movement intensity VT, m/s2 3.13 (.040) -.012 -.024;.000 -.017 -.035;.000 .057 
Movement intensity ML, m/s2 2.15 (.034) -.016 -.025;-.006 -.027 -.044;-.011 .001 
Movement intensity AP, m/s2 2.08 (.027) -.010 -.018;-.002 -.022 -.040;-.005 .013 
Gait symmetry       
Harmonic ratio VT 3.58 (.052) -.009 -.024;.007 -.010 -.027;.008 .28 
Harmonic ratio ML 2.83 (.043) -.020 -.032;-.008 -.027 -.043;-.010 .002 
Harmonic ratio AP 3.12 (.044) -.014 -.028;-.001 -.019 -.037;-.002 .034 
Gait variability       
Ampl. dominant freq. VT, psd 1.37 (.020) .009 .003;.015 .026 .008;.044 .004 
Ampl. dominant freq. ML, psd .77 (.018) .001 -.004;.006 .003 -.012;.019 .66 
Ampl. dominant freq. AP, psd .87 (.015) .002 -.002;.007 .009 -.009;.026 .33 
        
Chair Stand Test†       
Standard measure       
Duration chair stand test, s 12.9 (.16) .083 .034;.13 .035 .014;.056 .001 
Sit-to-stand       
Flexion duration, s .61 (.01) .002 .000;.004 .019 -.002;.040 .071 
Extension duration, s .55 (.01) .005 .003;.007 .045 .024;.065 <.001 
Flexion max. angular vel., °/s 172.3 (2.4) -.70 -1.47;.06 -.020 -.041;.002 .071 
Extension max. angular vel., °/s 59.9 (1.5) -.57 -1.04;-.11 -.025 -.046;-.005 .016 
Standing       
Duration, s .10 (.007) .003 .000;.005 .024 .003;.045 .022 
Sitting       
Duration, s .39 (.02) -.001 -.006;.005 -.003 -.025;.018 .75 
Stand-to-sit       
Flexion duration, s .58 (.01) .006 .003;.009 .043 .022;.063 <.001 
Extension duration, s .72 (.009) .002 .000;.005 .019 -.002;.039 .075 
Flexion max. angular vel., °/s 84.4 (1.6) -.95 -1.42;-.48 -.041 -.061;-.021 <.001 
Extension max. angular vel., °/s 141.4 (2.8) -1.19 -2.03;-.34 -.029 -.050;-.008 .006 
Abbreviations: n=number; β, estimate; CI, confidence interval; p, p-value; VT, vertical; ML, mediolateral; AP, 
anterior-posterior; ampl., amplitude; freq., frequency; max., maximum; vel., velocity; psd, power spectral density. 
Associations were assessed by linear regression and adjusted for gender and height. Unstandardized effect sizes 
and effect sizes with the physical performance parameters expressed as z-scores are given.*Values are expressed as 
mean (standard error). ‡Data available in n=292 and †n=221 participants.  
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Figure 3 Association of calendar age with standard clinical measures and instrumented measures of the 25-meter 
walk (A) and chair stand test (B). Estimated mean values expressed as z-scores are given in tertiles of calendar 
age. Error bars indicate standard error. Standard clinical measures are represented by walking speed and the total 
duration of the CST. Results are adjusted for gender and height. P-values indicate p for trend. Abbreviations: β, 
estimate; ML, mediolateral; VT, vertical. 
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maximum angular velocity of the extension phase. During the stand-to-sit phase, a higher 
calendar age was associated with a longer duration of the flexion phase and a slower 
maximum angular velocity of the flexion and extension phase. According to the sitting and 
standing phase, a higher calendar age was associated with a longer standing duration. 
Supplementary Table 1 shows the association of familial longevity with physical 
performance comparing offspring of nonagenarian siblings with their partners. No 
statistically significant difference was found between offspring and partners, except for the 
amplitude in the dominant frequency in AP direction. 
In Figure 3, the estimated mean values of the standard clinical and instrumented measures 
of the 25-meter walk (Figure 3A) and CST (Figure 3B) expressed as z-scores are presented 
in tertiles of calendar age. Similar effect sizes are shown for walking speed, used as 
standard clinical measure, movement intensity and the harmonic ratio in ML direction and 
the amplitude of the dominant frequency in VT direction. According to the CST, the effect 
sizes of the total duration of the CST as standard clinical measure and the extension and 
flexion duration of the sit-to-stand and stand-to-sit transfer, respectively, were similar. 
Discussion 
In this study population of middle-aged to older adults, physical performance assessed with 
the 25-meter walk and CST was lower at higher calendar age. The effect size for the 
standard clinical measures dependent on calendar age was similar to those of instrumented 
measures assessed with a body fixed sensor at the lower back. No statistically significant 
association was found between familial longevity and both standard clinical and 
instrumented measures of physical performance, comparing offspring of nonagenarian 
siblings with their partners. 
The association of calendar age with instrumented measures of the 25-meter walk was 
found in the four different gait domains that were measured, i.e. gait kinematics, stability, 
symmetry and variability. At higher calendar age, participants had a longer stride time and 
a lower movement intensity, i.e. a lower magnitude of the trunk acceleration, and less 
symmetrical gait pattern in ML and AP direction. This is in concordance with earlier 
findings in healthy older adults18-20 as well as in older adults with Parkinson’s Disease20 or 
dementia19. Because movement intensity is positively associated with walking speed21, the 
lower movement intensity might indicate that participants at higher age adapt their walking 
speed to remain a stable gait pattern. However, it is only possible to speculate about the 
order of changes in gait characteristics because the measurements were performed at the 
participant’s preferred speed and not at a fixed walking speed. The associations of gait 
stability and symmetry with calendar age were strongest in the ML direction, which is the 
direction that is in general strongly related to the ability to control balance and falls22,23. 
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Furthermore, participants with a higher calendar age had a more consistent and less variable 
gait pattern in VT direction, as was quantified by a higher amplitude of the dominant 
frequency of the signal’s power spectral density. So, additionally to walking speed the 
assessment of instrumented measures enhanced our understanding of changes in gait 
characteristics with calendar age. 
According to the instrumented measures of the CST, participants with a higher calendar age 
had in general longer durations and slower angular velocities in the different phases. This is 
in concordance with a previous study in a small sample of healthy young subjects and older 
adults recruited from a residential care home24. The strongest association with calendar age 
was found for the extension duration during the sit-to-stand phase and the flexion duration 
during the stand-to-sit phase. These phases represent the dynamic transitions during the 
CST7. The extension phase during the sit-to-stand phase represents the dynamic transition 
from a three-point stable support to a two-point stable support. The flexion phase during the 
stand-to-sit phase represents the dynamic transition in the other direction, from a two-point 
stable support to a three-point stable support. The necessity of a good balance control and 
the power to shift the center of mass of the trunk within the base of support in these 
dynamic transitions might explain the stronger association with calendar age compared to 
the other phases of the CST. 
The instrumented measures of the 25-meter walk and CST assessed in this study show 
similar effect sizes to changes in calendar age as the standard clinical measures, i.e. walking 
speed and total duration of the CST. These results indicate that both standard clinical and 
instrumented measures can be used for the detection of age-related changes in physical 
performance from middle age. The association of calendar age with specific instrumented 
measures of the 25-meter walk and CST in this study, i.e. gait stability and symmetry 
especially in the ML direction and the dynamic transition phase of the CST, enhanced our 
understanding of possible underlying mechanisms. Additionally to the standard clinical 
measures, addressing physical performance as a common output representing a combination 
of underlying systems, the instrumented measures indicated that especially a good balance 
control is an important determinant for the performance on both tasks. Future studies are 
needed to further investigate the potential added value of instrumented measures of balance 
control in the identification of sensitive markers for age-related changes in physical 
performance and understanding of underlying mechanisms. Finally, this might lead to the 
possibility to characterize different groups of individuals based on deterioration of specific 
underlying systems, like deterioration of the sensory system (including vision and the 
vestibular and proprioceptive system), low muscle mass or strength or cognitive 
impairment6, and development of interventions tailored to individual needs. 
No differences in performance on the 25-meter walk and CST were found between 
offspring of nonagenarian siblings and their partners as controls. Unless a significant 
Chapter 3 
– 38 – 
decline in physical performance during ageing, familial longevity as strong indicator of 
healthy ageing is not marked by a better physical performance at middle age. Besides the 
relatively young age of the participants, the shared environmental conditions of the 
offspring and partners might be an explanation leading to similar levels of daily physical 
activity in both groups by performing the activities together. This is supported by previous 
findings, showing no difference between offspring and partners among other major 
indicators of lifestyle like body mass index, current smoking and level of education25. 
Furthermore, these results indicate that the younger biological age of the offspring 
compared to their partners, based on the lower prevalence of age-related diseases12,25, better 
cognitive performance26, preserved insulin sensitivity27 and fewer senescent cells28 cannot 
be detected by physical performance at middle age. 
One of the strengths of this study is the study population consisting of middle-aged to older 
adults with a relatively good health status. This enhanced our insight into sensitive markers 
for age-related changes in physical performance already observable from middle age and 
without the presence of overt diseases. Furthermore, the inclusion of offspring of 
nonagenarian siblings and their partners made it possible to study whether standard clinical 
and instrumented measures of physical performance are sensitive to familial longevity. The 
assessment of different physical performance tests and the use of a body fixed sensor made 
it possible to assess the potential added value of instrumented measures in assessing age-
related changes in physical performance from middle age and to enhance our insight into 
possible underlying mechanisms. Future studies including a wider age range and specific 
patient populations with repeated measures taken over time are needed to further 
investigate this. A limitation is the availability of the CST in only 74% of the participants 
due to technical problems. However, missing data were randomly distributed. The distance 
of the walk trajectory is both a strength and a limitation. The distance of 25 m enabled the 
reliable assessment of instrumented measures of gait characteristics additional to walking 
speed. However, a longer distance or a higher number of strides is needed for the 
determination of gait characteristics like local dynamic stability and stride-to-stride 
variability measures16. These parameters have been shown to be associated with calendar 
age and to be important predictors of falls15,29,30 suggesting that they might be important 
parameters in the detection of age-related changes in physical performance as well. 
In conclusion, standard clinical and instrumented measures of physical performance are 
associated with similar effect sizes to age-related changes in physical performance in 
middle-aged to older adults. The assessment of instrumented measures needs further 
investigation to be able to distinguish different groups of individuals to ultimately tailor 
interventions to individual needs.  
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Supplementary material 
Supplementary Table 1 Physical performance dependent on familial longevity (offspring versus partner status*) 
presented unstandardized and expressed as z-score. 
   Unstandardized Expressed as z-score  
 Offspring§ Partners§ β 95% CI β 95% CI p 
25-meter Walk‡        
Standard measure        
Walking speed, m/s 1.45 (.01) 1.45 (.01) -.002 -.038;.035 -.011 -.24;.22 .93 
Gait kinematics        
Stride time, s .98 (.01) .98 (.01) -.005 -.019;.008 -.081 -.29;.13 .45 
Gait stability        
Movement intensity VT, m/s2 3.12 (.06) 3.14 (.05) .015 -.13;.16 .022 -.20;.24 .84 
Movement intensity ML, m/s2 2.15 (.04) 2.16 (.05) -.015 -.14;.11 -.025 -.24;.19 .82 
Movement intensity AP, m/s2 2.08 (.04) 2.07 (.04) -.007 -.11;.093 -.016 -.24;20 .89 
Gait symmetry        
Harmonic ratio VT 3.50 (.07) 3.67 (.07) .15 -.053;.36 .17 -.059;.41 .14 
Harmonic ratio ML 2.84 (.06) 2.82 (.06) -.056 -.22;.11 -.075 -.30;.15 .51 
Harmonic ratio AP 3.13 (.06) 3.11 (.07) -.030 -.21;.15 -.040 -.28;.20 .75 
Gait variability        
Ampl. dominant freq. VT, psd 1.34 (.03) 1.40 (.03) .070 -.010;.15 .21 -.031;.45 .088 
Ampl. dominant freq. ML, psd .77 (.03) .77 (.02) -.029 -.091;.034 -.095 -.30;.11 .37 
Ampl. dominant freq. AP, psd .91 (.02) .84 (.02) -.072 -.13;-.015 -.28 -.50;-.059 .013 
         
Chair Stand Test†        
Standard measure        
Duration chair stand test, s 12.8 (.22) 13.0 (.23) .30 -.30;.91 .12 -.13;.38 .33 
Sit-to-stand        
Flexion duration, s .61 (.01) .62 (.01) .002 -.024;.028 .018 -.26;.29 .90 
Extension duration, s .55 (.01) .55 (.01) .002 -.025;.030 .023 -.24;.29 .86 
Flexion max. ang. vel., °/s 169.9 (3.5) 174.9 (3.3) 4.16 -5.50;13.8 .12 -.15;.38 .40 
Extension max. ang. vel., °/s 58.6 (2.0) 61.3 (2.4) .93 -4.95;6.81 .041 -.22;.30 .76 
Standing        
Duration, s .10 (.01) .10 (.01) .003 -.025;.031 .024 -.23;.28 .85 
Sitting        
Duration, s .37 (.02) .40 (.03) .038 -.032;.11 .15 -.12;.42 .29 
Stand-to-sit        
Flexion duration, s .57 (.01) .58 (.01) .016 -.019;.052 .11 -.14;.36 .37 
Extension duration, s .72 (.01) .71 (.01) -.002 -.036;.032 -.016 -.28;.25 .90 
Flexion max. ang. vel., °/s 85.6 (2.2) 83.1 (2.2) -4.65 -10.7;1.39 -.20 -.46;.06 .13 
Extension max. ang. vel., °/s 142.1 (3.8) 140.7 (4.0) -3.70 -14.7;7.28 -.091 -.36;.18 .51 
Abbreviations: n=number; β, estimate; CI, confidence interval; p, p-value; VT, vertical; ML, mediolateral; AP, 
anterior-posterior; ampl., amplitude; freq., frequency; max., maximum; ang., angular; vel., velocity; psd, power 
spectral density. Associations were assessed by logistic regression and adjusted for calendar age, gender and 
height. Robust standard errors were used to account for familial relationships among the offspring. Unstandardized 
effect sizes and effect sizes with the physical performance parameters expressed as z-scores are given. *Offspring 
= 0, partner = 1. §Values are expressed as mean (standard error). ‡Data available in n=148 offspring and n=144 
partners and in †n=114 offspring and n=107 partners.  
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Abstract 
Background: The positive relationship between cognitive and physical performance has 
been widely established. The influence of brain structure on both domains has been shown 
as well. We studied whether the relationship between brain structure and physical 
performance is independent of cognitive performance. 
Methods: Cross-sectional analysis within 297 middle-aged to older adults (mean age (SD) 
65.4 (6.8) years). Memory function, executive function and physical performance measured 
by the tandem stance test, chair stand test (CST), 4-meter walk and 25-meter walk were 
assessed. Magnetic resonance imaging was available in 237 participants and used to 
determine the (sub)cortical gray matter, white matter, hippocampal and basal ganglia 
volumes and the presence of cerebral small vessel disease (CSVD), i.e. white matter 
hyperintensities, cerebral microbleeds (CMBs) and lacunar infarcts (LIs). Regression 
analysis was used adjusting for age, gender, education and whole brain volume. A 
Bonferroni correction was applied considering p-values <0.017 as statistically significant. 
Results: Poor memory function was associated with a slower 4-meter walking speed 
(p<0.01). No association was found between brain structure and cognitive performance. 
The presence of CMBs and LIs was associated with a slower 25-meter walking speed 
(p<0.001). This result did not change after additional adjustment for cognitive performance. 
Conclusions: In middle-aged to older adults, CMBs and LIs are associated with walking 
speed independent of cognitive performance. This emphasizes the clinical relevance of 
identifying each of the possible underlying mechanisms of physical performance, which is 
required for the development of timely and targeted therapies.  
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Introduction 
The positive relationship between cognitive and physical performance has been widely 
established. The role of higher-order cognitive performance, especially of executive 
functioning, in the performance of physical tasks has been shown as well as the influence of 
the level of physical activity and performance on risk of dementia and cognitive decline1-4. 
Because of the co-occurrence of cognitive and physical impairment frequently seen with 
advancing age, a common underlying cause such as brain pathology has been suggested5,6. 
Deterioration of several brain structures has been shown to be associated with cognitive and 
physical performance. Poor cognitive performance is commonly indicated by brain atrophy 
and accumulation of white matter hyperintensities (WMHs)7,8. Thereby, the association of 
hippocampal volume with global cognitive performance and memory function and of 
frontal gray matter volumes with executive function have been most consistently shown9. 
According to physical performance, especially the association of white matter atrophy and 
accumulation of WMHs with poor physical performance has been reported6. The relation 
with specific regional and subcortical gray matter volumes is less clear. The few studies 
incorporating different gray matter volumes showed that especially atrophy of the 
hippocampus and basal ganglia are associated with poor physical performance6,10,11. 
It is unclear whether the influences of cognitive performance and brain structure on 
physical performance are independent of each other. In this study, we assessed the 
relationship between cognitive and physical performance and the relationship of brain 
structure with both domains within a study population of relatively healthy middle-aged to 
older adults in the absence of overt diseases. 
Methods 
The Leiden Longevity Study 
The Leiden Longevity Study is a longitudinal cohort comprising of 421 long-lived 
Caucasian families of Dutch descent recruited between 2002 and 200612. Families were 
enrolled if at least two long-lived siblings were alive and fulfilled the age-criterion of 89 
years or older for males and 91 years or older for females. Additionally, the offspring of 
these long-lived siblings were included together with their partners as controls representing 
the general population13. For the current study, participants were recruited from this 
population of middle-aged to older adults visiting the research center during the follow-up 
measurement between September 2009 and December 2010. Participants were included if 
they had complete data on both cognitive and physical performance leading to 297 
participants (149 offspring and 148 partners). The Medical Ethical Committee of the Leiden 
University Medical Center approved the study and written informed consent was obtained 
from all participants. 
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Cognitive performance 
Cognitive performance was tested for two different cognitive domains; memory and 
executive function. Memory function was assessed by the immediate and delayed recall of 
the 15-Picture Learning Test (15-PLTi and 15-PLTd, respectively). For the immediate 
recall, fifteen pictures of well-known items were shown to the participant at three 
consecutive times. After each time, the participant was asked to recall as many pictures as 
possible. The sum of the number of correct pictures during the three trials was defined as 
the immediate recall. The delayed recall was defined as the number of correct pictures the 
participant was able to recall after 20 min. 
Executive function was assessed by attention and processing speed using the abbreviated 
Stroop test trial 3 and the Digit Symbol Substitution Test (DSST), respectively. The 
abbreviated Stroop test trial 3 consisted of a card containing 40 color words printed in a 
discongruous ink color. The participant was asked to name the ink color of the words as 
fast as possible. In the DSST, digits were given on a card as well as a key for the formation 
of specific digit-symbol combinations. The outcome parameter was the number of correct 
digit-symbol combinations the participant was able to make in 90 s. 
Physical performance 
Four different aspects of physical performance were assessed; the ability to maintain 
standing balance, the ability to rise from a chair and walking speed over a short and long 
distance14,15. The ability to maintain standing balance was assessed by the tandem stance 
test. Participants were asked to place their feet in tandem position, i.e. placing both feet in 
line with one foot touching the toe of the other foot, and maintain balance for 10 s. The 
chair stand test (CST) was used to assess the ability to rise from a chair. Participants were 
asked to stand up and sit down 5 times as quickly as possible from a straight-backed chair. 
The test was started in sitting position end ended when the participant was standing with 
straight back for the fifth time. Walking speed was assessed over 4 and 25 m of walking. 
During the 4-meter walking test, participants started from standing position and were 
instructed to walk at their preferred speed over a length of 5 m without slowing down 
before the 4-meter line. Time was started at the moment the first foot passed the starting 
line until the moment the first foot passed the 4-meter line completely. The fastest time out 
of two measurements was used for the calculation of walking speed. Walking speed during 
25 m of walking was assessed in steady state over a length of 30 m, i.e. time started at 2.5 
m and stopped at 27.5 m. Again, participants were asked to walk at their preferred speed. 
Mean walking speed over two measurements was used for analyses. 
During all physical performance tests, participants wore non-slip socks and a body fixed 
sensor (Dynaport® Hybrid, McRoberts BV, The Hague, the Netherlands) on the lower back 
positioned with an elastic belt at the height of the second lumbar vertebra. The sensor 
consisted of a triaxial accelerometer and three uniaxial gyroscopes of which the signals 
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were recorded with a sample frequency of 100 Hz. A remote control was used for marking 
the start and end of each measurement. 
Brain structure 
Magnetic resonance imaging (MRI) was used to determine whole brain volume, the cortical 
gray and white matter volumes, the subcortical gray matter volumes of the hippocampus 
and basal ganglia, including the nucleus accumbens, caudate nucleus, pallidum and 
putamen and the presence of cerebral small vessel disease (CSVD) including WMH volume 
and the presence of cerebral microbleeds (CMBs) and lacunar infarcts (LIs)16,17. Three-
dimensional (3-D) T1-weighted, T2-weighted, fluid attenuated inversion recovery (FLAIR) 
and T2*-weighted images were acquired using a whole-body MR system operating at a 
field strength of 3T (Philips Medical Systems, Best, the Netherlands) with the following 
imaging parameters: repetition time 9.7 ms, time to echo 4.6 ms, flip angle 8° and field of 
view 224x177x168 mm resulting in a normal voxel size of 1.17x1.17x1.4 mm. 
Different tools of the FMRIB Software Library (FSL, Release 5.0 (c) 2012)18,19 were used 
for the determination of brain volumes. Whole brain, gray matter and white matter volumes 
were calculated using the FSL-tool Structural Image Evaluation, using Normalization of 
Atrophy (SIENAX)20,21. For the determination of the subcortical hippocampus and basal 
ganglia volumes, the FMRIB’s Registration and Segmentation Tool (FIRST) was used. 
MRI scans were visualized using the freely available software Medical Imaging Processing, 
Analysis and Visualization (MIPAV). WMHs, CMBs and LIs were analyzed blinded to 
subject identity, sex, age and being offspring or partner by two independent reviewers. 
Discrepancies were re-analyzed in a consensus meeting with a third reviewer. WMHs were 
defined as areas within the cerebral white matter with increased signal intensity on both 
FLAIR and T2*-weighted images without mass effect. CMBs were defined as focal areas 
of signal void on T2-weighted images increasing in size on T2*-weighted imaged. Presence 
of LIs, defined as having a diameter >2 mm, was assessed on 3-D T1 weighted, FLAIR and 
T2-weighted images. The presence of CMBs and LIs was combined into one variable 
consisting of participants with either CMBs or LIs or both. Due to contraindications for 
MRI, data was available for 237 out of 297 (80%) participants. Most frequent reported 
contraindications were metal splinters, pacemaker and claustrophobia as was determined by 
application of the standard MRI patient questionnaire of the Leiden University Medical 
Center. 
Statistical analysis 
Continuous variables are presented as mean and standard deviation, non-Gaussian 
distributed variables as median and interquartile range, and categorical variables as number 
and percentage. 
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First, the association between cognitive and physical performance was assessed using linear 
regression analysis. Logistic regression analysis was used for the dichotomous outcome of 
the tandem stance test, i.e. participants being either unable or able to maintain 10 s of 
balance in tandem position. Results were adjusted for age, gender and education. 
Second, linear regression analysis was used to assess the relationship between brain 
structure and cognitive performance and subsequently between brain structure and physical 
performance. Again, logistic regression analysis was used for the tandem stance test. All 
measures of brain structure were expressed as z-scores. For the basal ganglia volume, a 
composite z-score was calculated by averaging the z-scores of the nucleus accumbens, 
caudate nucleus, pallidum and putamen. Results were adjusted for age, gender and whole 
brain volume. An additional adjustment model was used in the analysis of the relationship 
between brain structure and physical performance including besides age, gender and whole 
brain volume also cognitive performance. For this analysis, a composite z-score of 
cognitive performance was calculated by averaging the z-scores of the 15-PLTi, 15-PLTd, 
abbreviated Stroop test trial 3 (multiplied by minus one because of the reverse direction of 
scoring compared to the other cognitive performance tests) and DSST. 
The independent t-test and χ2 test were used to assess whether the characteristics of 
participants with and without MRI data were significantly different. Because of the number 
of dependent variables within each of the comparisons that were investigated, i.e. the 
relationship between cognitive and physical performance, brain structure and cognitive 
performance and brain structure and physical performance, a Bonferroni correction was 
applied to avoid type I errors. P-values lower than 0.017 were considered statistically 
significant. All statistical analyses were performed with SPSS version 22.0 (IBM Corp., 
Amonk, NY, USA). 
Results 
Characteristics of the participants are shown in Table 1. Mean age (SD) of all participants 
was 65.4 (6.8) years. 
Table 2 shows the association between cognitive and physical performance. According to 
memory function, participants with a worse performance on the immediate and delayed 
recall had a slower 4-meter walking speed. No associations were found for executive 
function or other physical domains. 
Table 3 and 4 present the association between brain structure and cognitive and physical 
performance, respectively. No association was found between brain structure and cognitive 
performance. According to the different domains of physical performance, the presence of 
CMBs and LIs was associated with a slower 25-meter walking speed. 
Brain structure and physical performance 
– 51 – 
Table 5 shows that additional adjustment for cognitive performance in the association 
between brain structure and physical performance did not change the results. There were no 
differences between the participants with and without MRI data, except for weight and the 
prevalence of cardiovascular disease, which were both higher in the group without MRI 
data (p=0.026 and p=0.021, respectively). 
Table 1 Characteristics of the participants. 
 All (N=297) 
Demographics  
Females, n (%) 150 (50.5) 
Age, years 65.4 (6.8) 
Education, years* 12 (10 - 15) 
Anthropometrics  
Height, cm 172.4 (8.5) 
Weight, kg 79.2 (14.1) 
Comorbiditiesa  
Diabetes mellitus, n (%) 18 (6.8) 
Cardiovascular disease, n (%)‡ 79 (29.8) 
Intoxications  
Users of alcohol, n (%)† 234 (79.1) 
Former and/or current smokers, n (%) 201 (67.9) 
Cognitive performance  
15-PLTi, correct pictures 30.1 (5.0) 
15-PLTd, correct pictures* 11 (10 - 13) 
Stroop time part 3, s* 46 (39 - 54) 
DSST, correct answers 47.1 (10.6) 
Physical performance  
Able to perform tandem stance, n (%) 286 (96.6) 
Duration of the chair stand test, s 12.6 (2.4) 
4-meter walking speed, m/s 1.13 (.20) 
25-meter walking speed, m/sb 1.45 (.16) 
Brain structure  
Whole brain volume, cm3c 1090 (92) 
Gray matter volume, cm3c 542 (39) 
White matter volume, cm3c 548 (61) 
Hippocampal volume, cm3c 8.0 (.8) 
Basal ganglia volume, cm3c 21.8 (2.2) 
WMH volume, cm3*d .50 (.083 - 2.2) 
Presence of CMBs/LIs, n (%)c 37 (15.7) 
Values are expressed as mean (standard deviation), unless otherwise indicated. *Values are expressed as median 
(interquartile range). ‡Defined as myocardial infarction, stroke and hypertension. †Using ≥1 units per week. 
Abbreviations: n, number; 15-PLTi and 15-PLTd, 15 Picture Learning Test immediate and delayed recall, 
respectively; DSST, Digit Symbol Substitution Test; WMH, white matter hyperintensity; CMBs, cerebral 
microbleeds; LIs, lacunar infarcts. Data available for an=265, bn=277, cn=237, and dn=211 participants. 
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Discussion 
In this study population of middle-aged to older adults, poor memory function was 
associated with a slower 4-meter walking speed. The presence of CMBs and LIs was 
associated with a slower 25-meter walking speed. No association was found between brain 
structure and cognitive performance, and the relationship between brain structure and 
physical performance did not change after adjustment for cognitive performance. 
The association between cognitive and physical performance has been confirmed by several 
studies1,2,22,23. However, these studies especially show the role of executive function in gait 
performance commonly illustrated by the performance of dual-tasks1,24-27. The association 
between memory function and physical performance has been shown less frequently; 
although the incorporation of memory processes in physical performance has been 
emphasized previously as well11,28,29. The association of memory function with the 4-meter 
walking speed and not with the 25-meter walking speed, suggests that specifically the 
initiation of movements relates to memory processes. In the 4-meter walk, walking speed 
was measured from starting position including the initiation phase instead of the steady 
state assessment of walking speed in the 25-meter walk. These findings are supported by a 
previous study in elderly outpatients, showing largest effect sizes of the association 
between cognitive performance and walking speed for the 4-meter walk compared to a 
steady state 10-meter walk and a 6-minute walk30. 
Among the different physical domains that were assessed, i.e. the ability to maintain 
standing balance, the ability to rise from a chair and walking speed over a short and long 
distance, brain structure was specifically associated with walking speed. This emphasizes 
the role of walking speed as important indicator of overall health status31,32. Of the two 
different walking tests that were performed, the 25-meter walking speed and not the 4-
meter walking speed was associated with brain structure, i.e. the presence of CMBs and 
LIs. This specific association might be explained by the dependence of longer distance 
walks on the cardiovascular determined endurance factor, considering that the presence of 
CMBs and LIs is accelerated by cardiovascular disease and vascular risk factors30,33. Unless 
the consistent associations of cortical and subcortical brain volumes with walking speed 
found in literature6, no association was found for each of the brain volumes in this study. 
These results might be explained by differences in calendar age between the study 
populations. Most studies showing a positive association between brain structure and 
walking speed are in slightly older populations (mean age of seventy years and older)6, 
while the null results of this study are in accordance with a previous study in a comparable 
population of healthy middle-aged to older adults walking at preferred speed over a long 
distance34. 
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The relationship between brain structure and physical performance did not change after 
adjustment for cognitive performance, which is consistent with the fact that we did not find 
an association between brain structure and cognitive performance. Previously, neither an 
association of measures of brain microstructure, i.e. mean magnetization transfer ratio 
(MTR), MTR histogram peak height, fractional anisotropy and mean diffusivity, with 
cognitive performance was found in this study population35. The relatively young age might 
explain these results if we compare them with the positive associations found in studies in 
older community-dwelling individuals without cognitive impairment9,36,37. Thereby, the 
measures used for the assessment of the relation between brain structure and cognitive 
performance might be not sensitive enough for this population9. Future studies focusing on 
which measures are most sensitive for these non-clinical populations might provide more 
insight into this. The association of the presence of CMBs and LIs with a slower 25-meter 
walking speed independent of cognitive performance suggests that the influences of brain 
structure and cognitive performance on physical performance are two independent 
processes. This is supported by the positive association found between memory function 
and 4-meter walking speed, while no association was found of the hippocampal volume, 
known to play an important role in memory function9,38, with 4-meter walking speed. These 
results therefore emphasize the importance of identifying possible underlying mechanisms 
of physical performance in order to be able to develop targeted therapies. Longitudinal 
studies covering a broader age range are needed to further explore this and to finally get 
insight into the optimal timing with respect to prevention and disease progression. 
One of the strengths of this study is the availability of data on cognitive and physical 
performance and for 80% of the participants on brain structure with all measurements of 
one participant performed on the same day. This enabled to get insight into the role of 
cognitive performance and brain structure on physical performance. The different cognitive 
and physical domains that were assessed enabled to specify this even further. The study 
population consisting of middle-aged to older adults enhanced our understanding of 
changes that are already observable from middle-age in the absence of overt diseases. As a 
result of this age range and good health status of the participants, the variation among 
participants able and unable to performance the tandem stance test was very low. This 
could have led to an underestimation of the associations of cognitive performance and brain 
structure with standing balance. Future studies are needed including a more demanding 
standing condition, for example with eyes closed, to further investigate the association of 
cognitive performance and brain structure with standing balance. Another limitation is the 
availability of MRI data in 80% of the participants due to contraindications for MRI. The 
higher prevalence of cardiovascular disease in the group of participants without MRI data is 
in concordance with our expectations because of the contraindications for MRI. Exclusion 
of these participants could have led to an underestimation of the results, in specific for the 
association of the presence of CSVD with 25-meter walking speed. 
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In conclusion, the presence of CMBs and LIs is associated with walking speed in middle-
aged to older adults, independent of cognitive performance. This supports that in this age 
range the influences of brain structure and cognitive performance on physical performance 
are two independent processes. Identifying the possible influence of these underlying 
mechanisms of physical performance is of clinical relevance in order to be able to develop 
targeted therapies with optimal timing to maintain physical performance with advancing 
age. 
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Abstract 
Background: Evidence is emerging that cognitive performance is involved in maintaining 
balance and thereby involved in falls in the elderly. The aim of this study was to investigate 
the association of cognitive status with measures of standing balance in elderly outpatients. 
Methods: In a cross-sectional study, 197 community-dwelling elderly (mean age (SD) 81.9 
(7.1) years) referred to a geriatric outpatient clinic were included and subsequently 
dichotomized into a group with low and normal cognitive status based on cut-off values of 
the Mini-Mental State Examination, Montreal Cognitive Assessment and Visual 
Association Test. The ability to maintain standing balance as well as the Center of Pressure 
(CoP) movement were assessed during 10 s of side-by-side, semi-tandem and tandem 
stance with eyes open and eyes closed. Logistic and linear regression were used to examine 
the association between cognitive status and measures of standing balance adjusted for age, 
gender and highest completed education. 
Results: Low cognitive status in elderly outpatients was associated with a lower ability to 
maintain 10 s of balance in side-by-side stance with eyes closed (Odds Ratio (OR) (95% 
CI): 3.57 (1.60;7.97)) and in semi-tandem stance with eyes open and eyes closed (OR (95% 
CI): 3.93 (1.71;9.00) and OR (95% CI): 2.32 (1.11;4.82), respectively). Cognitive status 
was not associated with CoP movement. 
Conclusion: Low cognitive status associates with a lower ability to maintain standing 
balance in more demanding standing conditions in elderly outpatients. This may have 
implications for routine geriatric screening strategies and interpretation of results of either 
standing balance or cognitive tests.  
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Introduction 
Impaired standing balance is one of the major complaints reported by elderly to physicians 
and is strongly related with falls1,2. Standing balance is required for most daily living 
activities. Impaired standing balance may easily result in serious medical, physical, 
emotional, and social consequences, including loss of independence and social isolation1,3. 
Understanding underlying determinants of impaired standing balance enables early 
detection and the development of tailored intervention. 
Standing balance depends on the functioning of multiple organ systems, like the sensory 
(vestibular, proprioceptive and visual), musculoskeletal, nervous and cardiovascular 
system4-6. Moreover, it becomes more and more evident that standing balance relies on 
high-order cognitive performance controlled by the cerebral cortex instead of being a fully 
automatic process7-9. The involvement of the cerebral cortex on standing balance may be 
mediated by corticospinal loops and communication with the cerebellum and basal 
ganglia10. Involvement may grow with advanced age as neuroimaging studies showed that 
elderly exhibit more elaborate brain activation compared to young controls during the 
performance of fine motor tasks11-14. Deterioration of the multiple organ systems with 
advanced age and diseases for which must be compensated may result in increased 
involvement of the cerebral cortex15. Changes in the white matter of the cortex, like 
leukoaraiosis and periventricular white matter change, are frequently found in dementia. 
Those changes may result in less ability to compensate and therefore could result in 
impaired balance and mobility decline16-18. 
Previous cross-sectional studies investigated the association between cognitive status with 
standing balance in relatively homogeneous and pre-specified study populations of middle-
aged to older adults. These studies showed that a lower cognitive status is associated with a 
lower ability to maintain standing balance19-22 and with increased Center of Pressure (CoP) 
movement15,23,24. CoP movement is a measure for the steadiness of the body while 
maintaining balance and is assessed using a force plate, which measures the ground 
reaction forces. In general, an increased CoP movement is assumed to reflect impaired 
standing balance. However, the association of cognitive status with standing balance 
remains to be established in a clinically relevant population. 
In this study, we assessed the association of cognitive status with the ability to maintain 
standing balance and Center of Pressure movement in a population of community-dwelling 
elderly referred to a geriatric outpatient clinic, with its typical variety of comorbidities, use 
of medication and mobility impairments. Elderly outpatients with low cognitive status were 
expected to exhibit worse standing balance, as reflected by less ability to maintain standing 
balance and increased CoP movement, compared with patients with normal cognitive 
status. 
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Methods 
Study setting 
The study population consisted of community-dwelling elderly (n=207) referred to a 
geriatric outpatient clinic in a middle-sized teaching hospital (Bronovo Hospital, The 
Hague, The Netherlands) between March 2011 and January 2012 for a comprehensive 
geriatric assessment (CGA)25. CGA was performed by trained nurses and medical staff 
during a 2-hour visit. All measurements were performed in the same conditions, in a quiet 
room and in a fixed order; first cognitive status tests, second standing balance tests. 
Therefore, the trained nurses and medical staff were aware of the cognitive status of the 
patient. Measurements took place between 9 am and 4 pm during the day. The study was 
reviewed and approved by the institutional review board of the Leiden University Medical 
Center (Leiden, the Netherlands). Because this research is based on regular patient care, the 
need for individual informed consent was waived. Ten patients (4.8%) were excluded from 
the analyses due to missing data, leaving 197 patients. 
Elderly outpatient characteristics 
Extensive characterization of the population for validity purposes was performed as 
described below. Patients were asked to complete questionnaires on marital status, living 
arrangements, highest completed education, current smoking and alcohol use. Body mass 
index (BMI) was assessed by measuring weight and height. Information on diseases and 
use of medication was extracted from medical records. Multimorbidity was defined as the 
presence of two or more diseases, including chronic obstructive pulmonary disease, heart 
failure, diabetes mellitus, hypertension, malignancy, myocardial infarction, Parkinson’s 
disease, (osteo)arthritis, transient ischemic attack and stroke. Depressive symptoms were 
assessed by the Hospital Anxiety and Depression Scale (HADS)26; a depression subscore 
higher than 8 out of 21 points indicated depressive symptoms. Physical functioning was 
assessed by handgrip strength, preferred gait speed during a steady state 10-meter walk and 
the Short Physical Performance Battery (SPPB)27. Furthermore, patients were asked to 
complete questionnaires on maximal daily physical activity, experienced falls during the 
previous 12 months and use of walking aids. 
Cognitive status 
Global cognitive status was assessed by Mini-Mental State Examination (MMSE)28 and 
Montreal Cognitive Assessment (MoCA)29, assessing executive function, arithmetic, 
memory and orientation in time and space. MMSE and MoCA scores both range from 0 to 
30 points. One point was added to the total MoCA score if the highest completed education 
was at low or middle level (comparable with <12 years of education). Version A of the 
Visual Association Test30, in which a maximum number of six objects can be recalled, was 
used to assess recollecting memory. VAT scores range from 0 to 6 points. For all cognitive 
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tests, lower scores indicate lower cognitive status. The tests scores of the three cognitive 
tests were combined to form two groups of patients, i.e. a group with low and a group with 
normal cognitive status. Low cognitive status was defined as scoring below clinically used 
cut-off values (MMSE <24 points, MoCA <23 points and VAT <3 points30-32) in minimal 
two out of three cognitive tests. If only two cognitive tests were available (n=40), low 
cognitive status was defined as scoring below clinically used cut-off values in minimal one 
cognitive test. The group including all other cases, i.e. scoring equal to or above the 
clinically used cut-off points, was defined as the normal cognitive status group. Patients 
with only one (n=1) or no cognitive tests (n=1) were excluded. 
Standing balance 
Ability to maintain standing balance 
The ability to maintain balance was measured in six standing conditions, i.e. three different 
standing positions characterized by a progressive narrowing of the base support both with 
the eyes open and eyes closed. Patients wore non-slip socks and were asked to maintain 
standing balance for 10 s without moving their feet, first with their feet as closely together 
as possible (side-by-side stance), second with the medial side of the heel of one foot 
touching the big toe of the other foot (semi-tandem stance) and third with both feet in line 
while the heel of one foot touched the toes of the other foot (tandem stance). A maximum 
of three trials for each condition was allowed in case standing balance was lost prematurely. 
When the patients were not able to maintain standing balance in a specific position within 
the three trials allowed, the consecutive more demanding condition was not performed. All 
standing conditions were performed in a fixed order, starting with the measurements with 
eyes open, as part of the SPPB, and subsequently with eyes closed. Six of the 197 patients 
(3.0%) did not attempt the standing positions with eyes closed due to lack of time or lack of 
motivation, leaving 191 patients for analyses of standing balance positions with eyes 
closed. 
Center of Pressure movement 
All standing conditions were performed on a triangular 6 degrees of freedom force plate 
(Forcelink BV, Culemborg, The Netherlands) to measure CoP movement during 10 s. Only 
successful trials (i.e. completion of 10 s of maintaining standing balance) were considered 
for further analysis. Due to technical problems (n=18) and unknown reasons (n=29), CoP 
movement was available for n=136 patients. 
As age-related differences have been shown to be most pronounced in medio-lateral (ML) 
direction33 and impaired ability to control balance in this direction is well associated with 
falls34, only CoP movement in ML direction was included in the analysis. Time series of 
CoP movement in ML direction were used to calculate five CoP parameters, i.e. the mean 
amplitude, the amplitude variability, the range, the mean velocity and the velocity 
variability. CoP parameters were transformed into z-scores, resulting in standardized CoP 
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parameters with a mean of 0 and standard deviation of 1. Averaging those z-scores resulted 
in a composite score of the CoP movement in ML direction33. 
Statistical analysis 
Continuous variables with Gaussian distribution are presented as mean and standard 
deviation (SD), otherwise as median and interquartile range (IQR) or number and 
percentage. Independent T-tests, Chi Square tests and Mann-Whitney tests were used to 
assess whether characteristics of both groups were significantly different. Logistic 
regression analysis was used to assess the association of cognitive status with the ability to 
maintain standing balance with adjustments for age, gender and highest completed 
education. The association of cognitive status with CoP movement was assessed using 
linear regression analysis with the same adjustments. Furthermore, a subgroup analysis was 
performed in all patients with available data of the HADS depression score (n=121), in 
which we additionally adjusted for depressive symptoms. The statistical package SPSS for 
Windows version 20.0 (SPSS Inc, Chicago, USA) was used for analyzing the data. P-values 
below 0.05 were considered statistically significant. Graphs were made with GraphPad 
Prism 5 (GraphPad Software, Inc., La Jolla, USA). 
Results 
The characteristics of the elderly outpatients are presented in Table 1 together with the 
characteristics stratified for low and normal cognitive status. Mean age (SD) of the patients 
was 81.9 (7.1) years. Measures of physical functioning, i.e. handgrip strength, gait speed 
and SPPB score, were lower in the low compared to the normal cognitive status group. The 
number of self-reported fall incidents in the previous 12 months was higher in the low 
cognitive status group. 
Figure 1 shows the percentage of elderly outpatients able to maintain balance in different 
standing conditions stratified for low and normal cognitive status. Ability to maintain 
balance decreased in both groups with increasing difficulty of standing condition. Less than 
2% of the patients were able to maintain tandem stance with eyes closed. 
The CoP movement in ML direction is shown in Supplementary Table 1. The CoP 
parameters, used to calculate the CoP composite scores, were higher in more difficult 
standing conditions. 
Cognitive status and standing balance 
Ability to maintain standing balance 
The association between cognitive status and the ability to maintain standing balance is 
given in Figure 2. Patients in the low cognitive status group were less likely to be able to 
maintain standing balance in the semi-tandem stance with eyes open (Odds Ratio (OR)  
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(95% CI): 3.93 (1.71;9.00)) and in the side-by-side and semi-tandem stance with eyes 
closed (OR (95% CI): 3.57 (1.60;7.97) and OR (95% CI): 2.32 (1.11;4.82)) compared with 
patients in the normal cognitive status group. The odds ratio was higher for side-by-side 
stance with eyes closed compared with semi-tandem stance with eyes closed. Additional 
adjustment for depressive symptoms did not change the results (data not shown). 
Table 1 Elderly outpatient characteristics. 
  Cognitive status  
 All (N=197) Low (N=56) Normal (N=139) p 
Socio-demographics     
Age, years 81.9 (7.1) 83.0 (7.5) 81.5 (6.9) 0.19 
Men, n (%) 78 (39.6) 19 (33.9) 58 (41.7) 0.31 
Widowed, n (%) 80 (41.5) 23 (41.8) 56 (41.2) 0.94 
Independent living, n (%) 154 (79.4) 40 (72.7) 113 (82.5) 0.13 
Highest completed education, n (%)    0.44 
  Low 48 (24.7) 17 (31.5) 31 (22.5)  
  Middle 62 (32.0) 18 (33.3) 42 (30.4)  
  High 55 (28.4) 12 (22.2) 43 (31.2)  
  University 29 (14.9) 7 (13.0) 22 (15.9)  
Current smoking, n (%)a 22 (16.2) 4 (10.5) 18 (18.8) 0.25 
Excessive alcohol use, n (%)* 8 (4.1) 1 (1.9) 7 (5.1) 0.32 
Health characteristics     
BMI, kg/m2b 25.8 (4.5) 25.8 (4.0) 25.7 (4.7) 0.90 
Multimorbidity, n (%)†b 95 (50.3) 22 (40.0) 72 (54.5) 0.07 
Median number of medication (IQR)b 5 (3-7) 5 (3 - 7) 5 (3 - 7) 0.45 
HADSd > 8 points, n (%)‡c 28 (23.1) 9 (25.7) 19 (22.6) 0.72 
Physical functioning     
Handgrip strength, kg 26.1 (8.2) 24.1 (8.4) 27.0 (8.0) 0.028 
Gait speed, m/s§b 0.87 (0.29) 0.73 (0.32) 0.93 (0.26) <0.001 
Median SPPB, points (IQR) 7 (5-10) 6 (4 - 8) 8 (6 - 10) <0.001 
Indoor daily physical activity, n (%) 31 (16.0) 6 (10.7) 25 (18.1) 0.20 
Fall incident previous 12 months 127 (64.5) 45 (80.4) 80 (57.6) 0.003 
Use of walking aid 108 (55.1) 36 (64.3) 71 (51.4) 0.10 
Cognitive status     
Median MMSE, points (IQR) 27 (24 - 29) 22 (19 - 24) 28 (27 - 29) <0.001 
Median MoCA, points (IQR)d 24 (20 - 26) 18 (15 - 20) 25 (23 - 27) <0.001 
Median VAT, points (IQR) 5 (3 - 6) 2 (1 - 4) 6 (5 - 6) <0.001 
All parameters are presented as mean with standard deviation unless indicated otherwise. Abbreviations: BMI, 
body mass index; HADSd, depression subscore of the Hospital Anxiety and Depression Scale; IQR, interquartile 
range; SPPB, Short Physical Performance Battery; MMSE, Mini-Mental State Examination; MoCA, Montreal 
Cognitive Assessment; VAT, Visual Association Test. *Defined as >14 units per week for females or >21 units per 
week for males. †Present in case of two or more diseases, including chronic obstructive pulmonary disease, heart 
failure, diabetes mellitus, hypertension, malignancy, myocardial infarction, Parkinson's disease, (osteo)arthritis, 
transient ischemic attack and stroke. ‡Present with a depression subscore >8 on the Hospital Anxiety and 
Depression Scale. §Preferred gait speed during a steady state 10-meter walk. Data available in an=136, bn=190, 
cn=121 and dn=158. 
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Figure 1 Percentage of elderly outpatients able to maintain balance in different standing conditions, i.e. side-by-
side, semi-tandem and tandem stance with eyes open and eyes closed. Results are stratified for low and normal 
cognitive status. 
 
Figure 2 Forest plot of the association between cognitive status and the ability to maintain balance in different 
standing conditions, i.e. side-by-side, semi-tandem and tandem stance with eyes open and eyes closed. The low 
and normal cognitive status groups are represented by 0 and 1, respectively. The ability to maintain standing 
balance is defined as 0 not being able to maintain standing balance and 1 being able to maintain standing balance. 
Results are presented in odds ratios and 95% confidence intervals adjusted for age, gender and highest completed 
education. Abbreviations: OR, odds ratio; CI, confidence interval; n.a., not applicable, number of elderly 
outpatients able to maintain balance in the standing condition is <5. 
 
Table 2 Association between cognitive status and Center of Pressure movement in medio-lateral direction in 
different standing conditions. 
 Side-by-side†   Semi-tandem‡  Tandem§ 
 β SE p   β SE p  β SE p 
Cognitive status*            
Eyes open -0.02 0.18 0.91  0.17 0.21 0.43  0.29 0.35 0.41 
Eyes closed 0.35 0.19 0.07   0.29 0.29 0.32    n.a.   
*Cognitive status with 0 representing the group of elderly outpatients with low cognitive status and 1 the group 
with normal cognitive status based on clinically used cut-off values. Dependent variable: Center of Pressure 
composite score in medio-lateral direction. Results are adjusted for age, gender and highest completed education. 
Abbreviations: β, estimate; SE, standard error; p, p-value; n.a., not applicable, number of elderly outpatients able 
to maintain balance in the standing condition is <5. Data available in †n=135 and n=116, ‡n=119 and n=72, §n=56 
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Center of Pressure movement 
Table 2 shows the results of the association of cognitive status with CoP movement in ML 
direction. The association was not statistically significant for each standing position, both 
with eyes open and eyes closed. The association between cognitive status and CoP 
movement in ML direction during tandem stance with eyes closed was not applicable due 
to a low number of patients who could perform this standing condition. 
Discussion 
The aim of this study was to establish the association of cognitive status with standing 
balance in a clinically relevant population of elderly outpatients. We found that low 
cognitive status was associated with a lower ability to maintain standing balance. Cognitive 
status was not associated with CoP movement in ML direction. 
Our findings are in concordance with previous studies showing a cross-sectional 
association between low cognitive status and a lower ability to maintain standing balance in 
middle-aged to older adults in which the study population is further specified on e.g. 
cognitive or mobility impairments and the presence of comorbidities19-22. In this study, we 
showed that this relation is also present in community-dwelling elderly visiting the geriatric 
outpatient clinic with common comorbidities and mobility impairments. In this population, 
deterioration of the different organ systems involved in standing balance, i.e. the sensory, 
musculoskeletal, nervous and cardiovascular system, is very likely. The presence of the 
association between cognitive status and the ability to maintain standing balance supports 
the important role of the brain in controlling standing balance instead of being a fully 
automatic process7-9. Furthermore, it emphasizes the clinical relevance of measuring 
standing balance in patients with low cognitive status. Especially because of the large 
impact of impaired standing balance on most of daily living activities and the strong 
relation of impaired standing balance with falls1,2. The latter is also supported by this study 
showing a higher reported fall incidence over the previous 12 months in the low compared 
to the normal cognitive status group. No differences in maximal daily physical activity 
were found between groups. Although, in this case it is difficult to distinguish cause and 
effect, as less daily activity could be caused by impaired standing balance, but less daily 
activity could also cause impaired standing balance. 
The association between cognitive status and the ability to maintain standing balance was 
found in 3 of the 6 standing conditions, namely side-by-side stance with eyes closed and 
semi-tandem stance with eyes open and eyes closed. This could be explained by the 
increasing difficulty of the standing conditions, i.e. reducing the base of support and 
eliminating visual information. More difficult standing conditions put higher demands on 
balance control. Aforementioned standing conditions will therefore be more difficult for 
patients with a low cognitive status compared with patients with a normal cognitive status. 
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No association between cognitive status and the ability to maintain balance in tandem 
stance with eyes closed could be found, as only four patients were able to maintain balance 
during this condition. 
No association was found between cognitive status and CoP movement. The inconsistency 
in the association of cognitive status with the ability to maintain standing balance and CoP 
movement emphasizes that both outcome parameters of standing balance assess different 
properties. The ability to maintain standing balance is a measure of standing balance 
referring to whether someone is able to stay upright or not, whereas CoP movement is a 
more indirect measure of standing balance referring to the steadiness of the body while 
standing on a force plate35. A possible explanation for the absence of an association of 
cognitive status with CoP movement, is that data on CoP movement is only available from 
patients who were able to maintain 10 s of standing balance, which may have led to an 
underestimation of the association between cognitive status and CoP movement. Another 
possible explanation is the heterogeneity of the study population, especially the presence of 
more than two diseases in more than 50% of the patients and the deterioration of multiple 
systems involved in standing balance4. As each underlying system could have a different 
effect on CoP movement, this may interfere with the association between cognition and 
CoP movement on population level36. Further research into the assessment of CoP 
movement is still needed to get insight into the causal underlying mechanisms of impaired 
standing balance, which are yet unknown. 
One of the strengths of this study is the study population consisting of community-dwelling 
elderly referred to a geriatric outpatient clinic. Because no exclusion criteria were used, the 
study population represents an average population encountered in common geriatric 
practice. This makes the results of this study highly relevant in clinical practice. Measuring 
standing balance in patients with low cognitive status and, the other way around, measuring 
cognitive status in patients with impaired standing balance will have an added value in 
clinical care. Furthermore, the combined assessment of the ability to maintain standing 
balance, as part of the SPPB, and CoP movement enables to get insight into the clinical 
utility of both measures. A limitation of the study is that CoP movement was measured 
during a relatively short time interval of 10 s and data of only one successful trial was 
available, while previous studies recommend to measure CoP movement more than once 
and during a longer time period35,37. However, in clinical practice and in a population of 
elderly outpatients it is likely that this it is not feasible due to time limit and fatigue. The 
cross-sectional design of the present analysis prevents to study causality. 
In conclusion, low cognitive status is associated with a lower ability to maintain balance for 
10 s in more demanding standing conditions in elderly outpatients. This indicates the 
clinical relevance of measuring standing balance in patients encompassing those with low 
cognitive status in routine geriatric screening. Regarding interpretation, in patients with 
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impaired standing balance the possibility of low cognitive status must be considered and, 
the other way around, in case of poor performance on cognitive tests the possibility of 
impaired standing balance must be considered. We could not establish an additional value 
of assessment of CoP movement in routine geriatric assessment as we found low cognitive 
status not to be associated with CoP movement. A next step would be to focus on clustering 
of phenotypes and defining risk populations, which will be of clinical added value and will 
allow to investigating causality. This obviously requires large study sample sizes. 
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Supplementary material 
Supplementary Table 1 Center of Pressure (CoP) movement, represented by CoP parameters, within elderly 
outpatients able to maintain different standing positions with eyes open and eyes closed in medio-lateral direction. 
 Side-by-side* Semi-tandem† Tandem‡ 
Eyes open    
Mean amplitude, cm 0.60 (0.02) 0.72 (0.03) 0.72 (0.03) 
Range, cm 3.51 (0.13) 4.25 (0.18) 3.92 (0.17) 
Mean velocity, cm/s 4.09 (0.10) 4.78 (0.13) 5.41 (0.21) 
Amplitude variability, cm 0.75 (0.03) 0.91 (0.04) 0.88 (0.04) 
Velocity variability, cm/s 5.70 (0.14) 6.76 (0.23) 7.55 (0.28) 
    
Eyes closed    
Mean amplitude, cm 0.85 (0.03) 1.03 (0.04)  
Range, cm 4.86 (0.18) 5.64 (0.23)  
Mean velocity, cm/s 5.67 (0.15) 6.76 (0.26) n.a. 
Amplitude variability, cm 1.06 (0.04) 1.27 (0.05)  
Velocity variability, cm/s 7.88 (0.20) 9.33 (0.37)   
Data are given in mean with standard error. Abbreviations: n.a., not applicable, number of elderly outpatients able 
to maintain balance in the standing condition is <5. Data available in *n=136 and n=119 and †n=120 and n=75 for 
eyes open and closed, respectively and ‡n=56 for eyes open.  
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Abstract 
Background: Walking speed is shown to be an important indicator of health status and 
function in older adults and part of the comprehensive geriatric assessment in clinical 
practice. The present study aimed to assess the influence of different assessment methods 
on walking speed and its association with key aspects of poor health status, i.e. the presence 
of low cognitive performance and cardiopulmonary disease. 
Methods: In 288 community-dwelling elderly (mean age 82.2 ± 7.1 years) referred to a 
geriatric outpatient clinic, walking speed was assessed with the 4-meter, 10-meter and 6-
minute walking test. 
Results: Mean walking speed assessed with the 10-meter walking test was higher compared 
to the 4-meter and 6-minute walking test (mean difference (95% CI) 0.11 (0.10; 0.13) m/s 
and 0.08 (0.04; 0.13) m/s, respectively). No significant difference was found in walking 
speed assessed with the 4-meter compared to the 6-minute walking test (mean difference 
(95% CI) -0.03 (-0.08; 0.03) m/s). ICCs showed excellent agreement of the 4-meter with 
the 10-meter walking test and fair to good agreement of the 6-minute with the 4-meter as 
well as 10-meter walking test. The presence of low cognitive performance was negatively 
associated with walking speed, with the highest effect size for the 4-meter walking test. The 
presence of cardiopulmonary disease was negatively associated with walking speed as well, 
with the highest effect size for the 6-minute walking test. 
Conclusions: In the clinically relevant population of elderly outpatients, walking speed and 
its interpretation depends on assessment method, which therefore cannot be used 
interchangeably in clinical practice.  
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Introduction 
Walking underlies many physical functions and reflects the interaction of several 
underlying systems, such as the central and peripheral nervous system, sensory systems, 
muscles, bones and joints, and the cardiopulmonary system1. A dysfunction in any system 
may slow walking speed. Therefore, walking speed is an important indicator of health 
status and function and can be used as a ‘vital sign’2-4. It has been shown that walking 
speed associates with aspects of poor health status or outcomes in older adults, such as 
mortality5-8, mobility impairment7,9,10, falls8,11, presence of cognitive impairment2,13 and 
cardiopulmonary diseases7,14-16, hospitalization and nursing home placement5,8,11,17. Cut-off 
values for walking speed are used for prediction of aforementioned health outcomes and 
underpin clinical decision making. 
Walking speed is often measured in clinical practice as part of a comprehensive geriatric 
assessment (CGA)18 and in clinical research19. It is a quick and easy measure and is not 
limited to specific equipment. Furthermore, it is a valid, sensitive and specific measure with 
high interrater and test-retest reliability20-23. Currently, there are many methods to assess 
walking speed varying in pace (i.e. normal or as fast as possible), static or dynamic start 
and walking distance or time. Previous research showed conflicting results regarding 
methodologically induced variance in assessed walking speed in elderly24,25. This hampers 
comparison of different studies and may affect clinical interpretation of walking speed23,26. 
In this study, we assessed the influence of different assessment methods on walking speed 
in a clinically relevant population of community-dwelling elderly referred to a geriatric 
outpatient clinic. Walking tests varied in distance or time and static or dynamic start. 
Furthermore, we examined the association of walking speed assessed by different methods 
with the presence of low cognitive performance and cardiopulmonary disease as key 
aspects of poor health status influencing walking speed. 
Methods 
Setting 
This cross-sectional study included 299 community-dwelling elderly referred to a geriatric 
outpatient clinic in a middle-sized teaching hospital (Bronovo Hospital, The Hague, the 
Netherlands) for a CGA between October 2010 and January 2012. CGA was performed 
during a 2-hour visit including questionnaires and measurements of physical and cognitive 
performance. Trained nurses or medical staff performed all tests. Medical charts were 
evaluated retrospectively. As this study is based on regular medical care, the need for 
individual informed consent was waived. In the present analyses, 11 (3.7%) patients were 
excluded due to missing data on all three walking tests (10 due to physical impairments and 
1 due to time constraints), resulting in 288 patients. 
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Outpatient characteristics 
Patients completed questionnaires, which provided information on age, gender, marital 
status, living arrangements, smoking and alcohol use. Body Mass Index (BMI) was 
calculated by dividing body weight in kilograms by the square of the height in meters. 
Medical charts were used to determine use of medication and presence of diseases, i.e. 
hypertension, myocardial infarction, chronic obstructive pulmonary disease (COPD), 
malignancy, diabetes mellitus, rheumatoid arthritis, (osteo)arthritis and Parkinson’s disease. 
Multimorbidity was defined as having two or more diseases. The presence of 
cardiopulmonary disease was defined as having one or more diseases and risk factors 
relating to the cardiovascular and/or pulmonary system, i.e. hypertension, myocardial 
infarction and COPD. Depressive symptoms were assessed by the Hospital Anxiety and 
Depression Scale (HADS)27; a depression subscore higher than 8 out of 21 points indicated 
depressive symptoms. Cognition was assessed through the Mini-Mental State Examination 
(MMSE)28. A relative MMSE score was calculated by dividing the total MMSE score by 
the maximal possible MMSE score multiplied by 30. The presence of low cognitive 
performance was defined as scoring below the clinically used cut-off value of 24 points29. 
Physical functioning was assessed by handgrip strength, the Short Physical Performance 
Battery (SPPB)30 and questionnaires about walking difficulties and the use of a walking aid. 
Walking speed 
Walking speed was assessed with the 4-meter, 10-meter and 6-minute walking test. Patients 
wore non-slip socks during the 4- and 10-meter walking test and their regular shoes during 
the 6-minute walking test. The walking tests were performed without walking aid, unless 
the patients were not able to. 
The 4-meter walking test was assessed as part of the SPPB and was performed twice. 
Patients started from standing position and were instructed to walk at their preferred speed 
over a length of 5 m, without slowing down before the 4-meter line. Time was measured 
using a hand-held stopwatch from the moment the first foot passed the starting line until the 
moment the first foot passed the 4-meter line completely. The shortest time was used for 
analysis. 
The 10-meter walking test was performed twice and patients were instructed to walk at 
their preferred speed over a length of 15 m. Time was started at 2.5 m and stopped at 12.5 
m, resulting in a steady state measurement over 10 m. Time was measured using a hand-
held stopwatch and the shortest time was used for analysis. 
The 6-minute walking test was performed once and patients were instructed to walk as far 
as possible, without running, for 6 min. The test started from standing position and stopped 
after 6 min or if patients could not walk further. Patients walked down a corridor of 15 m 
and the number of times patients walked down the corridor was recorded manually plus any 
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residual distance. A Dynaport Hybrid (McRoberts BV, The Hague, The Netherlands), a tri-
axial accelerometer positioned on the lower back using an elastic strap at the height of the 
second lumbar vertebra, was used as a second measure of total walking distance. The 
number of turns was established off line by custom written software using Matlab (The 
MathWorks Inc., Natick, Massachusetts, U.S.A.). Subsequently, the counted turns were 
multiplied by 15 and the reported residual distance was added. For the current analysis, the 
total distance calculated using the Dynaport Hybrid was used for further analysis. As the 6-
minute walking test was only performed between October 2010 and March 2011, data was 
available in 70 patients, of which 7 (12.9%) patients were not able to finish the test due to 
fatigue or shortness of breath. 
Statistical analysis 
Continuous variables with Gaussian distribution are presented as mean and standard 
deviation (SD), otherwise as median and interquartile range (IQR) or as number (n) and 
percentage (%). Paired samples t-tests were used to assess the systematic error, i.e. the 
mean difference, between the different methods to assess walking speed, i.e. 4- versus 10-
meter, 4-meter versus 6-minute and 10-meter versus 6-minute walking test. Absolute 
agreement was assessed by the 95% limits of agreement (95% LOA), which were 
calculated by the mean difference ± 1.96 SD31,32 and visualized using Bland-Altman plots. 
Relative agreement was assessed by the Intraclass Correlation Coefficient (ICC3,1)33. The 
ICC values were interpreted as excellent (0.75 or higher), fair to good (0.40 to 0.75) or poor 
(0.40 or lower)25. The association of cognitive performance and cardiopulmonary diseases 
with walking speed assessed by three different walking tests was tested using linear 
regression analysis with adjustments for age and gender. Data was analysed using SPSS 
version 20.0 for Windows (SPSS Inc., Chicago, USA). P-values below 0.05 were 
considered statistically significant. 
Results 
Outpatient characteristics 
The characteristics of the elderly outpatients are shown in Table 1. Mean age (SD) was 82.2 
(7.1) years and 35.1% were men. 
Comparison of walking speed assessed with different methods 
Mean differences between walking speed assessed with different walking tests are 
presented in Table 2 and visualized in Figure 1. Walking speed assessed with the 10-meter 
walking test was significantly higher compared to the walking speed assessed with the 4-
meter and 6-minute walking test. Walking speed assessed with the 4-meter and 6-minute 
walking test were not significantly different. The 95% LOA of the comparison of the 4-
meter and 10-meter walking test was lower than the 95% LOA of the comparison of the 6-
minute walking test and the 4-meter walking test and the 95% LOA of the comparison of 
Chapter 6 
– 80 – 
the 6-minute walking test and the 10-meter waking test. The ICC between the 4- and the 
10-meter walking test was excellent. The ICCs between the 4-meter and 6-minute walking 
test and between the 10-meter and 6-minute test were fair to good. 
Table 1 Characteristics of elderly outpatients referred to a geriatric outpatient clinic. 
 All (N=288) 
Demographics  
Age, years 82.2 (7.1) 
Men, n (%) 101 (35.1) 
Widowed, n (%) 117 (41.3) 
Independent living, n (%)a 236 (83.1) 
Current smoking, n (%)c 22 (16.1) 
Excessive alcohol use, n (%)*a 9 (3.2) 
Health characteristics  
BMI, kg/m²b 25.9 (4.5) 
Multimorbidity, n (%)†b 103 (37.5) 
Cardiopulmonary disease, n (%)$b 169 (61.0) 
Number of medication, median (IQR)a 5 (3-7) 
HADS depression‡c 30 (23.4) 
MMSE, pointsa 27 (24-29) 
Physical functioning  
Measured  
Handgrip strength, kg 25.4 (8.0) 
SPPB score, points; median (IQR)a 7 (5-9) 
Self-reported, n (%)  
Walking difficulties 218 (76.8) 
Use of walking aid 167 (58.6) 
Walking speed  
4-meter walking speed, m/sa 0.72 (0.27) 
10-meter walking speed, m/sb 0.84 (0.28) 
6-minute walking speed, m/sd 0.75 (0.26) 
Variables are presented as mean (standard deviation) unless indicated otherwise. Data available in an=280-283, bn 
=275-279, cn=137, dn=70. *Defined as >14 units per week for females or >21 units per week for males. †Defined as 
having ≥2 diseases, including hypertension, myocardial infarction, chronic obstructive pulmonary disease, 
malignancy, diabetes mellitus, rheumatoid arthritis, (osteo)arthritis and Parkinson’s disease. $Defined as having ≥1 
cardiopulmonary diseases; hypertension, myocardial infarction and chronic obstructive pulmonary disease. 
‡Present with a depression subscore >8 on the Hospital Anxiety and Depression Scale. Abbreviations: BMI, body 
mass index; IQR, interquartile range; SPPB, Short Physical Performance Battery; MMSE, Mini Mental State 
Examination. 
Table 2 Comparison of walking speeds assessed with different walking tests. 
Walking test Mean difference, m/s 95% LOA p value ICC 95% CI 
4 m  ̶  10 m -0.11 -0.13; -0.10 <0.001 0.79 0.44; 0.90 
4 m  ̶  6 min -0.03 -0.08; 0.03 0.34 0.64 0.48; 0.76 
10 m  ̶  6 min 0.08 0.04; 0.13 <0.001 0.71 0.52; 0.82 
Data is presented in intraclass correlation coefficients and mean differences obtained from paired samples t-tests. 
Abbreviations: LOA, limits of agreement; ICC, intraclass correlation coefficients; CI, confidence interval. 
Walking speed in elderly outpatients 
– 81 – 
Figure 1 Bland-Altman plot representing the comparison between a) the 4-meter and 10-meter walking speeds, b) 
the 4-meter and 6-minute walking speeds and c) the 10-meter and 6-minute walking speeds. The solid line 
represents the mean difference in walking speed, while the dashed lines represent the upper and lower 95% limits 
of agreement (mean difference ± 1.96 SD). 
 
Association of underlying systems with walking speed 
Table 3 shows the association of the presence of low cognitive performance and 
cardiopulmonary disease with walking speed assessed with different walking tests. 
Presence of low cognitive performance was significantly associated with a lower 4-meter 
walking speed and 10-meter walking speed after adjustments for age and gender, of which 
the 4-meter walking speed showed the highest effect size. Presence of cardiopulmonary 
disease was significantly associated with a lower 4-meter, 10-meter and 6-minute walking 
speed after adjustments for age and gender, of which the 6-minute walking speed showed 
the highest effect size. 
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Table 3 Association between cognitive performance and cardiopulmonary disease with walking speed assessed 
with different walking tests. 
 4-meter walking speed 10-meter walking speed 6-minute walking speed 
 Beta (SE) p value Beta (SE) p value Beta (SE) p value 
Cognitive performance       
unadjusted -0.103 (0.038) 0.007 -0.091 (0.041) 0.027 0.032 (0.071) 0.66 
adjusted* -0.103 (0.035) 0.004 -0.095 (0.037) 0.012 0.018 (0.066) 0.79 
Cardiopulmonary disease      
unadjusted -0.069 (0.034) 0.039 -0.047 (0.035) 0.185 -0.107 (0.045) 0.088 
adjusted* -0.083 (0.031) 0.008 -0.064 (0.032) 0.047 -0.111 (0.055) 0.046 
Data is presented in the effect size (Beta) and standard errors (SE). Low cognitive performance is defined as 
scoring below the clinically used cut-off value of 24 (0=normal, 1=low); Cardiopulmonary disease is defined as 
having 1 or more cardiopulmonary diseases (0=absent, 1=present). *adjusted for gender and age. 
Discussion 
In a population of community-dwelling elderly referred to a geriatric outpatient clinic, 
walking speed was assessed with three different methods, i.e. the 4-meter, the 10-meter and 
the 6-minute walking test. Walking speed assessed with the 10-meter walking test was 
significantly higher compared to walking speed assessed with the 4-meter and 6-minute 
walking test. ICC values indicated excellent agreement for the comparison between the 4-
meter and 10-meter walking test and fair to good agreement for the 4-meter and 6-minute 
walking test and for the 10-meter and 6-minute walking test. The presence of low cognitive 
performance showed the strongest association with walking speed assessed with the 4-
meter walking test, while presence of cardiopulmonary disease showed the strongest 
association with walking speed assessed with the 6-minute walking test. 
No previous studies investigated the influence of different methods to assess walking speed 
in a clinically relevant population of elderly outpatients with comorbidities and mobility 
impairments. A previous study in a homogeneous population of healthy elderly showed an 
excellent agreement in walking speed assessed with the 4- and 10-meter walking test25, 
which is comparable with our results. A lower ICC value with a larger 95% LOA compared 
with aforementioned study, can be explained by a difference in study population and 
sample size. In contrast to the present results, other previous studies performed in healthy 
older adults and older adults with neurologic conditions reported no effect of walking 
distance on walking speed24,26. Apart from the differences in study population, it is difficult 
to compare aforementioned studies due to differences in test protocols, especially in pace 
and static or dynamic start of the walking test. 
Walking speed assessed with the 10-meter walking test was significantly higher compared 
to walking speed assessed with the 4-meter walking test. The higher walking speed 
assessed with the 10-meter walking test can be explained by the exclusion of the 
acceleration phase, which is included in the 4-meter walking test, while the 10-meter 
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walking test measures only the steady state phase. The results showed an excellent relative 
agreement between the 4-meter and 10-meter walking tests by the ICC. This means a high 
consistency between tests, i.e. smaller difference between both assessed walking speeds 
compared with the differences between the patients within the group. A small range of the 
95% LOA indicated a low random error and precise assessments of walking speeds. 
A systematically lower walking speed assessed with the 6-minute walking test compared to 
the 10-meter walking test was found, which can be explained by the inclusion of the 
acceleration phase and the endurance needed to perform the 6-minute walking test. The 
difference between both assessed walking speeds is somewhat higher compared to the 
differences between the patients in the study population, as shown by the ICC values 
indicating fair to good agreement. The large range of the 95% LOA indicated a high 
random error and less precise assessments of walking speeds. This may be explained by the 
introduction of more variability due to differences in endurance between patients. 
Furthermore, data of the 6-minute walking tests was limited available. 
We found no systematic difference between walking speed assessed with the 4-meter and 
the 6-minute walking test. Both tests include factors with a limiting effect on the assessed 
walking speed, i.e. an acceleration phase and endurance. The first factor has less effect on 
walking speed assessed with the 6-minute walking test, as the duration of the 6-minute 
walking test is longer compared with the 4-meter walking test. Endurance only has effect 
on the 6-minute walking test. The results showed a fair to good relative agreement between 
the tests, due to a somewhat higher difference between the tests compared with the 
differences within the group reflected by the ICC. A large range of the 95% LOA indicates 
a high random error and less precision between the two assessed walking speeds. An 
explanation for this may be the introduction of more variability due to differences in 
endurance as well as the lower number of patients who performed the 6-minute walking test 
compared to the 4-meter walking test. 
The methodology to assess walking speed affects the association of cognitive performance 
with walking speed. In accordance with other studies performed in community-dwelling 
elderly and healthy elderly12,13,34-37, we found an association between the presence of low 
cognitive performance and walking speed assessed by respectively the 4-meter and 10-
meter walking test. The largest effect size was found for the walking speed assessed with 
the 4-meter walking test. This may be explained by the inclusion of the acceleration phase 
in the 4-meter walking test. Initiation of movement requires cognitive processes and 
therefore cognitive impairment slows walking13,37, resulting in a larger effect size for the 
association between presence of low cognitive performance and walking speed assessed 
with the 4-meter walking test. 
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The methodology also affects the association between the presence of cardiopulmonary 
disease and walking speed. In accordance with previous studies showing a negative 
association between hypertension, myocardial infarction and COPD and walking speed7,14-
16, we found an association between presence of cardiopulmonary disease with a lower 
walking speed. The highest effect size was found for the walking speed assessed with the 6-
minute walking test. This may be explained by the cardiovascular determined endurance 
factor, which is obviously more prominent in the 6-minute walking test. 
The results found in this study are of high clinical relevance. Previous studies reported 
clinically meaningful changes in walking speed in community-dwelling older adults for the 
4-meter walking test of 0.12 m/s38. More in general, small and substantial clinically 
meaningful changes in walking speed were reported from 0.05 m/s and 0.10 m/s, 
respectively38,39. In this study, we found differences in walking speeds of 0.11 m/s for the 
10-meter compared to the 4-meter walking test and 0.06 m/s for the 10-meter compared to 
the 6-minute walking test. Especially for the 10-meter compared to the 4-meter walking 
test, the range of 95% LOA is small (0.10;0.13 m/s) indicating that for 95% of the patients 
the difference between the 10-meter and 4-meter walking test will be between these values. 
So, the difference between both walking tests is large and precise enough to measure 
clinically meaningful changes in walking speed over time at the individual level when these 
methods are used interchangeably, which will have direct influence on clinical decision 
making. Furthermore, this study emphasizes that when using cut-off values3,8,11,40 for 
clinical decision making, clinicians should be aware that they depend on the assessment 
method of walking speed. 
The strength of this study is the large clinically relevant study population of elderly 
outpatients. No exclusion criteria were applied which further improves the generalizability 
of our results. Within the study population 64.9% were women, representing the geriatric 
outpatient population. Limitations were the limited availability of data on the 6-minute 
walking test. This could have influenced our results, as this reduces the power in the 
comparison of the 4- and 10-meter walking test with the 6-minute walking test and results 
in a methodologically induced enhancement of the 95% LOA and lower ICC values. 
This study showed that in the clinically relevant population of elderly outpatients, the 
walking test that has been used has direct influence on the assessed walking speed as well 
as its validity, illustrated by the association with two major underlying systems, i.e. 
cognition and the cardiopulmonary system. Walking speeds assessed by different walking 
tests are therefore not interchangeable in this population. Clinicians assessing elderly 
outpatients should be aware of the effect of the used walking test on the assessed walking 
speed and its consequences for clinical decision making.  
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Abstract 
Background: Cognitive and physical impairment frequently co-occur in older people. The 
aim of this study was to assess the temporal order of these age-related changes in cognitive 
and physical performance and to assess whether a relationship was different across specific 
cognitive and physical domains and age groups. 
Methods: Cognitive domains included global, executive and memory function; physical 
domains included gait speed and handgrip strength. These domains were assessed in two 
population-based longitudinal cohorts covering the age ranges of 55 – 64, 65 – 74, 75 – 85 
and 85 – 90 years with a follow-up of five to twelve years. Cross-lagged panel models were 
applied to assess the temporal relationships between the different cognitive and physical 
domains adjusting for age, sex, education, comorbidity, depressive symptoms and physical 
activity. 
Results: Over all age groups, poorer executive function was associated with a steeper 
decline in gait speed (p<0.05). From the age of 85 years, this relationship was found across 
all cognitive and physical domains (p<0.02). From the age of 65 years, slower gait speed 
and/or weaker handgrip strength were associated with steeper declines in global cognitive 
function (p<0.02), with statistically significant results across all cognitive domains in the 
age group of 75 – 85 years (p<0.04). 
Conclusions: The temporal relationship between cognitive and physical performance differs 
across domains and age, suggesting a specific rather than a general relationship. This 
emphasizes the importance of repeated measurements on different domains and encourages 
future research to the development of domain and age specific interventions.
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Introduction 
Cognitive and physical performance are important determinants of independent living and 
quality of life. Deterioration of both frequently co-occurs in older people1-3. The temporal 
order of age-related changes in cognitive and physical performance is largely unknown. 
Several longitudinal studies assessed the order of changes in only one of the possible 
directions; cognitive performance being associated with changes in physical performance or 
physical performance being associated with changes in cognitive performance4. 
The few longitudinal studies assessing the relationship between cognitive and physical 
performance in both directions, showed inconsistent results with uni- as well as 
bidirectional relationships5-10. Differences in findings between studies assessing different 
cognitive and physical domains might indicate dependence of the temporal relationship on 
these domains4. Furthermore, it has become more and more evident in recent years that 
results might differ across different age ranges, especially for older populations aged 75 and 
older11-13. Insight into whether the temporal relationship between cognitive and physical 
performance depends on age could provide important information for an effective clinical 
assessment, development and application of interventions. 
The aim of this study was to assess the temporal relationship between cognitive and 
physical performance; whether poor cognitive performance is associated with a steeper 
decline in physical performance or poor physical performance with a steeper decline in 
cognitive performance; and to study whether a relationship was different across specific 
cognitive and physical domains and age groups. 
Methods 
Study design and populations 
Two population-based longitudinal cohorts were included; the Longitudinal Aging Study 
Amsterdam (LASA) and the Leiden 85-plus Study. LASA is an ongoing study consisting of 
a nationally representative sample of the middle-aged to older Dutch population14. A 
random sample, stratified by age and gender, was drawn from the population registers of 11 
municipalities in three culturally distinct geographical areas in the Netherlands. In total, 
3107 participants aged 55 – 85 years (born between 1908 and 1937) were enrolled during 
the first data collection in 1992-1993 and have been followed up with a time interval of 
approximately three years. For the present study, data were used from the first four LASA 
cycles (1992-1993, 1995-1996, 1998-1999, and 2001-2002) in order to have the older ages 
sufficiently represented during the entire follow-up. The study was approved by the Ethical 
Review Board of the VU University Medical Center. Informed consent was obtained from 
all participants. 
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The Leiden 85-plus Study includes inhabitants of the city of Leiden, the Netherlands15. All 
inhabitants who reached the age of 85 years were eligible to participate. There were no 
selection criteria on health, functioning or demographic characteristics. In total 599 persons 
participated, which was 87% of all eligible inhabitants. Follow-up measurements were 
performed annually until the age of 90 years. The study was approved by the Medical 
Ethical Committee of the Leiden University Medical Center. All participants or guardians 
of the participants gave informed consent. 
A full description of the cognitive and physical tests and the potential confounders is given 
in the Supplementary Methods section. A short explanation is given below. 
Cognitive performance 
Cognitive performance was assessed by three different measures: global cognitive function 
and the domain specific measures of executive and memory function. Global cognitive 
function was assessed by the Mini-Mental State Examination (MMSE). Information 
processing speed was used as measure of executive function, which was assessed by the 
Alphabet Coding Task-15 and the Letter Digit Substitution Task (LDST) in LASA and the 
Leiden 85-plus Study, respectively. Memory function was assessed with the 15-Words test 
in LASA and the 12-Picture Learning test in the Leiden 85-plus Study. 
For all cognitive tests, a higher score indicates better cognitive performance. In LASA, 
cognitive performance was assessed in each LASA cycle. In the Leiden 85-plus Study, 
global cognitive function was assessed yearly. Executive and memory function were 
assessed yearly as well until MMSE score was below 19 points. 
Physical performance 
Physical performance was assessed by gait speed and handgrip strength. Gait speed was 
measured over a total distance of six meters (two times three meters with a turn), starting 
from standing position at maximal pace. Handgrip strength was measured by maximal 
squeeze using a hand held dynamometer. In LASA, gait speed was assessed in each cycle 
and handgrip strength from the second cycle. In the Leiden 85-plus Study, gait speed was 
assessed at the age of 85, 86, 87, and 89 years and handgrip strength at the age of 85 and 89 
years. 
Potential confounders 
The following factors were included as potential confounding variables as these are found 
to be associated with both cognitive and physical performance: education to indicate 
participant’s socio-economic status16, comorbidity17,18, depressive symptoms19,20 and 
physical activity21,22. 
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Figure 1 Cross-lagged panel model for estimation of the cross-lagged effects between cognitive and physical 
performance with confounding variables age, sex, education, number of comorbidities, depressive symptoms and 
physical activity. The model included synchronous and autoregressive correlations indicated by the semi-dotted 
and dotted arrows, respectively. Abbreviations: #, number; YCn, measurements of cognitive performance at time 
point n; YSn, measurements of gait speed or handgrip strength at time point n; BCS, cross-lagged effect of different 
cognitive domains on gait speed/handgrip strength; BSC, cross-lagged effect of gait speed/handgrip strength on 
different cognitive domains. 
 
 
Figure 2 Flow chart of participants of the Longitudinal Ageing Study Amsterdam (LASA) and Leiden 85-plus 
Study included in the cross-lagged panel models. Abbreviations: N, number. 
 
Statistical analyses 
For descriptive reasons we provided means and standard deviations (SD) for normal 
distributed continuous variables, the median and interquartile range (IQR) for non-Gaussian 
distributed continuous variables, and the number per category and percentages for 
categorical variables. 
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Cross-lagged panel models (CLPM) were used to examine the cross-lagged effects of 
cognitive performance on changes in physical performance and of physical performance on 
changes in cognitive performance during follow-up adjusted for potential confounders 
(Figure 1). CLPMs are a specific type of structural equation models, i.e. models allowing to 
estimate a number of regression equations simultaneously23. CLPMs allow simultaneous 
modelling of bidirectional, temporal relationships5,10. This means that the variables of 
interest (cognitive and physical performance) are the dependent variable in one regression 
equation and the independent variable in another regression equation. Hypothesized causal 
associations can be tested if the assumptions of the models are met, which is when there is 
synchronicity, stationarity and stability within and between the variables of interest24. 
Synchronicity means that cognitive and physical performance are measured at the same 
time, which is the case in both cohorts. Stationarity and stability presume that the causal 
process and autocorrelations do not change during follow-up, respectively. Therefore, 
effects in the CLPM were constrained to be equal, that is equal synchronous correlations, 
equal cross-lagged correlations and equal autocorrelations. Residuals of the variables for 
which synchronous correlation was estimated were allowed to correlate to take into account 
the effect of unknown third variables25. Residuals were further allowed to correlate over 
time. The standardized cross-lagged effects, i.e. expressing the effect in standard 
deviations, were used to compare the strength of the cross-lagged effects of cognitive 
performance on physical performance with the cross-lagged effects of physical 
performance on cognitive performance. To compare the effects across LASA and the 
Leiden 85-plus Study, the unstandardized cross-lagged effects in the Leiden 85-plus Study 
were multiplied by three (for handgrip strength after division by four) to make them 
comparable to the three year unstandardized cross-lagged effects in LASA. The cross-
lagged panel models were evaluated using MPlus (version 7)26, which uses the Full 
Information Maximum Likelihood procedure for handling missing values27. Model fit was 
evaluated on the following criteria: root mean square error of approximation (RMSEA) 
≤0.06, standardized root mean square residual (sRMR) ≤0.08 and comparative fit index 
(CFI) ≥0.9528. If all degrees of freedom have been used to estimate the model, the model is 
saturated and thus perfectly fits the data. 
Participants of the Leiden 85-plus Study not able to walk at baseline were excluded from 
the analyses leading to 526 (88%) participants (Figure 2). In both cohorts, the criterion of 
the presence of at least one follow-up measurement of gait speed was applied leading to 
2545 (82%) participants in LASA and 434 (83% of the 526 participants able to walk) 
participants in the Leiden 85-plus Study. In order to get good model fits, gait speed values 
below 0.1 m/s were changed to missing data (7 and 13 measurements of all baseline and 
follow-up measurements in total in LASA and the Leiden 85-plus Study, respectively). In 
the Leiden 85-plus Study, executive and memory function were only assessed in 
participants with a MMSE score of 19 points or higher resulting in 392 out of the 434 
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(90%) participants for these cognitive tests at baseline. To get insight into the temporal 
relationship between cognitive and physical performance across age, the LASA cohort was 
stratified into three age groups: participants aged 55 – 64 years, 65 – 74 years and 75 – 85 
years. P-values <0.05 were considered as statistically significant. Figures were made with 
GraphPad Prism 5 (GraphPad Software, Inc. La Jolla, USA). 
Results 
Baseline characteristics on demographics, health and cognitive and physical performance 
are shown in Table 1. Mean age (SD) for each of the different age groups of the LASA 
cohort was 60.2 (2.8), 69.8 (2.9) and 80.0 (2.9) years. Participants of the Leiden 85-plus 
Study were all 85 years of age at baseline. Table 2 shows the fit statistics for the cross-
lagged panel models. The statistics indicate good model fits for all models. 
Figure 3 shows the unstandardized cross-lagged effects of different cognitive domains on 
gait speed and handgrip strength during follow-up. For the age group of 55 – 64 years, 
poorer executive and memory function were associated with a steeper decline in gait speed. 
For the age groups of 65 – 74 and 75 – 85 years, poorer executive function was associated 
with a steeper decline in gait speed. Among the oldest age group of 85 – 90 years, poorer 
performance on each of the cognitive domains was associated with a steeper decline in gait 
speed and handgrip strength. 
Figure 4 shows the unstandardized cross-lagged effects of gait speed and handgrip strength 
on different cognitive domains during follow-up. No association was found for the 
youngest age group of 55 – 64 years. For the age group of 65 – 74 years, slower gait speed 
and weaker handgrip strength were associated with a steeper decline in global cognitive 
function. Among the age group of 75 – 85 years, slower gait speed was associated with a 
steeper decline on each of the cognitive domains. For the age group of 85 – 90 years, 
weaker handgrip strength was associated with a steeper decline in global cognitive function. 
Supplementary Tables 1 and 2 present the standardized cross-lagged effects of different 
cognitive domains on gait speed and handgrip strength during follow-up and of gait speed 
and handgrip strength on different cognitive domains during follow-up, respectively. 
Comparing the standardized cross-lagged effects of the temporal relationships that were 
statistically significant in both directions, similar effect sizes were found.
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Table 1 Baseline characteristics of the participants of the two study cohorts stratified for age. 
 LASA  Leiden 85+ Study 
 55 – 64 yrs. 
(N=887) 
65 – 74 yrs. 
(N=831) 
75 – 85 yrs. 
(N=827) 
 85 – 90 yrs. 
(N=434) 
Demographics      
Age, years 60.2 (2.8) 69.8 (2.9) 80.0 (2.9)  85 
Females, n (%) 462 (52.1) 451 (54.3) 445 (53.8)  289 (66.6) 
Education      
  Years* 9.0 (6.0 - 11.0) 9.0 (6.0 - 11.0) 6.0 (6.0 - 10.0)  - 
  Lower education, n (%) - - -  167 (38.5) 
Health characteristics      
BMI, kg/m2a 26.7 (3.7) 26.8 (4.0) 27.1 (4.5)  27.3 (4.4) 
Comorbidities* 0.0 (0.0 - 1.0) 1.0 (0.0 - 1.0) 1.0 (0.0 - 2.0)  2.0 (1.0 - 3.0) 
Depressive symptoms, points      
  CES-D score* 5.0 (2.0 - 9.0) 5.0 (2.0 - 11.0) 7.0 (3.0 - 12.0)  - 
  15-item GDS scoreb* - - -  1.0 (1.0 - 3.0) 
Physical activity      
LASA quest.c*, hrs./day 2.9 (1.8 - 4.4) 2.7 (1.6 - 4.0) 2.0 (1.2 - 3.1)  - 
TSP quest.*, points - - -  7.0 (5.0 - 9.0) 
Cognitive performance      
MMSE*, points 28.0 (27.0 - 29.0) 28.0 (27.0 - 29.0) 27.0 (25.0 - 28.0)  27.0 (24.0 - 28.0) 
Processing speed, # comb.      
  adj. Alphabet Coding Taskd 28.2 (6.5) 25.0 (6.5) 19.5 (6.6)  - 
  LDSTe* - - -  17.0 (13.0 - 22.0) 
Immediate recall      
  15 Words Test, # wordsd* 21.0 (18.0 - 25.0) 19.0 (15.0 - 23.0) 16.0 (12.0 - 19.0)  - 
  12-PLT, # picturesb* - - -  25.0 (21.0 - 29.0) 
Delayed recall      
  15 Words Test, # wordsd* 6.0 (4.0 - 8.0) 5.0 (3.0 - 7.0) 4.0 (2.0 - 5.0)  - 
  12-PLT, # picturesb* - - -  9.0 (7.0 - 11.0) 
Physical performance      
Gait speed, m/sf 0.96 (0.28) 0.86 (0.28) 0.69 (0.24)  0.55 (0.22) 
Handgrip strength*, kgg 30.5 (23.5 - 40.0) 27.0 (21.0 - 37.5) 22.0 (17.5 - 30.0)  22.0 (18.0 - 28.0) 
Variables are expressed as mean (standard deviation) unless indicated otherwise. 
Abbreviations: N, number; BMI, body mass index; CES-D, Centre for Epidemiologic 
Studies Depression Scale; GDS, Geriatric Depression Scale; quest., questionnaire; hrs., 
hours; TSP, Time Spending Patterns; MMSE, Mini-Mental State Examination; comb.; 
combinations; LDST, Letter Digit Substitution Test; 12-PLT, 12 Picture Learning Test; #, 
number. *Values expressed as median (interquartile range). Data are available in an=795, 
730 and 658 for each of the age groups between 55 and 85 years, respectively; bn=390; 
cn=786 and 759 for each of the age groups between 65 and 85 years, respectively; dn=815, 
735 and 665 for each of the age groups between 55 and 85 years, respectively; en=377; 
fn=777 and 740 for each of the age groups between 65 and 85 years, respectively; and 
gn=237, 668 and 596 for each of the age groups between 55 and 85 years, respectively. 
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Figure 4 Unstandardized cross-lagged effects and 95% confidence intervals of gait speed and handgrip strength 
on different cognitive domains during follow-up. Cross-lagged panel models were adjusted for age, sex, 
education, number of comorbidities, depressive symptoms and physical activity. Abbreviations: BSC, 
(unstandardized) cross-lagged effect of gait speed/handgrip strength on different cognitive domains; MMSE, 
Mini-Mental State Examination; #, number. *p<0.05, **p<0.01, ***p<0.001 An explanatory note for interpretation 
of the results in this figure is given in the Supplementary results section. 
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Discussion 
In two large population-based longitudinal cohorts, the temporal relationship between 
cognitive and physical performance differed across specific cognitive and physical domains 
and across age groups. The temporal relationship was most prominent from the age of 75 
years. Thereby, an inversed temporal order was found comparing the age groups of 75 – 85 
years and 85 – 90 years. Slower gait speed was associated with steeper declines on each of 
the cognitive domains in the age group of 75 – 85 years, while poorer performance on each 
of the cognitive domains was associated with steeper declines in gait speed and handgrip 
strength in the age group of 85 – 90 years. Across all age groups, poorer executive function 
was associated with a steeper decline in gait speed. 
Our specific findings across the different age groups might explain the inconsistent findings 
in the current literature. They support the findings of bidirectional relationships when broad 
age ranges are used6 and unidirectional relationships in study populations consisting of 
more specific age ranges and health status7-9. Furthermore, our results are in accordance 
with the results of the few studies that used cross-lagged modelling as well instead of 
regression modelling. These studies, consisting of 70 to 79 years old participants, indicated 
the presence of bidirectional relationships5,10 and a predominance of the relationship in the 
temporal order of slow gait speed being associated with steeper declines in global and 
executive function10, which supports our findings in the age group of 75 to 85 years. 
The temporal relationship between cognitive and physical performance was most prominent 
from the age of 75 years. From this age, deterioration of underlying systems such as the 
central and peripheral nervous, musculoskeletal and cardiovascular system29,30, is generally 
more substantial, which might lead to a more significant role of cognitive and physical 
performance as compensating mechanisms for each other. Thereby, the potential influence 
of physical performance on cognitive performance especially reached the level of 
significance in the age range of 75 – 85 years. This was particularly shown in gait speed, 
which emphasizes the role of gait speed as important indicator of health status31,32. The 
influence of cognitive performance on physical performance was found across the entire 
age range for executive function and gait speed, with consistent findings across all 
cognitive and physical domains for participants aged 85 years and older. This more 
elaborate influence of cognitive performance on physical tasks with advancing age is 
supported by previous studies showing that already from middle age several additional 
brain areas are recruited as compensating mechanism during the performance of physical 
tasks when compared to younger adults33,34. Thereby, the findings of a temporal 
relationship of executive function with gait speed across all age groups emphasize the 
important role of this cognitive domain in the performance of physical tasks35,36. The 
presence of the temporal relationships also in the younger age groups indicates the potential 
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role of these measures of cognitive and physical performance as early markers for the 
identification of physical and cognitive impairments, respectively. Based on the results in 
this study, poor executive function below the age of 75 years might be an early marker for 
physical impairments and slow gait speed and weak handgrip strength for cognitive 
impairments. 
The strength of the temporal relationships between cognitive and physical performance for 
each of the two different directions was similar. These findings indicate the potential 
effectiveness of cognitive and physical interventions to delay physical and cognitive 
impairment, respectively22,37,38. Especially on the effectiveness of physical interventions 
several studies have been performed showing reduced risks on cognitive decline and 
dementia22,37,39. Based on the results in this study, these effects might be most effective in 
the age range of 75 – 85 years. Future studies investigating the possible dependence of 
these interactions on age and the effectiveness of cognitive interventions especially from 
the age of 85 years are needed. Furthermore, the bidirectionality of the temporal 
relationship and similar strength of the effect sizes makes involvement of common 
underlying pathologies of age-related changes in cognitive and physical performance likely. 
One of the potential mechanisms that have been suggested is the presence of brain 
pathologies as common underlying etiology, which is supported by several cross-sectional 
and longitudinal studies showing the association between brain pathology and cognitive 
and physical performance40-42. Common biological processes throughout the entire human 
body, like cellular senescence, are suggested as well43. The results of this study encourage 
further research to possible common underlying determinants of cognitive and physical 
decline. 
One of the strengths of this study is the large sample size and availability of repeated 
measurements of the same cognitive and physical domains. Additional to the current 
literature, the temporal relationship between cognitive and physical performance was 
assessed by cross-lagged panel models enabling to get insight into the temporal order of 
age-related changes in cognitive and physical performance. The large age range of 55 – 90 
years and assessment of different cognitive and physical domains enhanced our 
understanding of how the relationship between cognitive and physical performance changes 
with age. A limitation is the population existing of two different longitudinal cohorts. 
Although both cohorts consisted of community-dwelling participants and the assessments 
of the cognitive and physical domains and potential confounders were comparable, 
differences might have influenced the results. Thereby, the selection of comparable 
cognitive tests resulted in a restricted battery, especially according to the assessment of the 
complex domain of executive function. According to the Leiden 85-plus Study, executive 
and memory function (as well as the GDS) were only assessed in participants with an 
MMSE score of 19 points or higher in order to get valid results. This loss of power might 
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have resulted in an underestimation of the temporal relationships between cognitive and 
physical performance. The exclusion of participants unable to walk and with less than one 
follow-up measurement has probably led to an underestimation of the results as well. 
In conclusion, the temporal relationship between cognitive and physical performance 
differs across domains and age, suggesting a specific rather than a general relationship. 
Especially from the age of 75 years, consistent temporal relationships of gait speed with 
different cognitive domains during follow-up were found, with an inversed temporal order 
from the age of 85 years. This emphasizes the importance of repeated measurements of 
cognitive and physical performance on different domains and the need for future studies 
investigating the potential dependency of cognitive and physical interventions based on 
these domain and age specific findings. 
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Cognitive performance was assessed by three different measures: global cognitive function, 
information processing speed as measure of executive function and memory function. In 
both studies, global cognitive function was assessed by the Mini-Mental State Examination 
(MMSE)44. The MMSE consists of 20 items and scores range from 0 to 30 points, with 
higher scores indicating better cognitive performance. In LASA, cognitive performance 
was assessed in each LASA cycle. Among the participants of the Leiden 85-plus Study, 
global cognitive function was assessed yearly. Executive and memory function were 
assessed yearly as well until MMSE score was below 19 points. 
In LASA, information processing speed was assessed by an adjusted version of the 
Alphabet Coding Task-1545. In this task, a row of characters is shown to the participant 
with an empty row below it. The participant is asked to name the correct corresponding 
characters based on the character combinations given at the top of the sheet and to work as 
quickly and accurately as possible. Three consecutive trials of one minute each were 
performed. The number of completed character combinations made up the score of each 
trial. The mean score of the three trials was used for statistical analyses. In the Leiden 85-
plus Study, the Letter Digit Substitution Task (LDST) was used to assess information 
processing speed. The LDST is a modified version of the Symbol Digit Modalities Test46. 
During this test, the participant is asked to make as many letter-digit combinations as 
possible according to a given key. Outcome parameter is the number of correct 
combinations within 60 seconds. For both tests, a higher score indicates better cognitive 
performance. 
Memory function was assessed with the 15-Words test47 and 12-Picture Learning test48 in 
LASA and the Leiden 85-plus Study, respectively. In the 15-Words test, which is the Dutch 
version of the Auditory Verbal Learning Test49, 15 words are presented verbally by the 
interviewer. Outcome parameters were the immediate and delayed recall, defined as total 
number of correct words during three consecutive trials and number of correct words after a 
distraction period of 20 minutes, respectively. Higher scores on both outcome parameters 
indicate better cognitive performance. Two versions of the 15 Words Test were used in 
consecutive LASA cycles in order to reduce a possible practice effect. The 12-Picture 
Learning Test consists of 12 pictures of different objects that are shown to the participant. 
Outcome parameters are again the immediate recall and delayed recall after 20 minutes. 
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Physical performance 
Physical performance was assessed by gait speed and handgrip strength. Gait speed was 
measured over a 3-meter course created with a measuring line at the participant’s home. 
Participants were asked to walk to the other end of the course, to turn around and walk back 
as fast as possible. The use of an assistive device was allowed when needed. The test 
started from a standing position and total time was measured by use of a stopwatch. Gait 
speed was assessed in each LASA cycle and at the age of 85, 86, 87 and 89 years in the 
Leiden 85-plus Study. 
Handgrip strength was measured to the nearest kilogram using a hand held dynamometer 
(Takei Scientific Instruments CO. Ltd., Tokyo, Japan in LASA and Sammons Preston Inc, 
BolingBrook, IL in the Leiden 85-plus Study). The width of the dynamometer’s handle was 
adjusted to hand size. Participants were instructed to squeeze with maximal strength. In 
LASA, handgrip strength was measured twice for each hand. Outcome parameter was the 
mean of the highest values on each hand. If only one value was available (e.g. only one trial 
for left or right hand or only measurements of one hand), this value was used. Handgrip 
strength was measured from the second LASA cycle onwards. In the Leiden 85-plus Study, 
handgrip strength was defined as the highest value during three trials measured on the 
dominant hand. Handgrip strength was measured at age 85 and 89 years. 
Potential confounders 
The following factors were included as potential confounding variables as these are found 
to be associated with both cognitive and physical performance: education to indicate 
participant’s socio-economic status16; comorbidity17,18,29, depressive symptoms19,20,50 and 
physical activity21,22,51,52. 
In LASA, education was expressed in years. Comorbidity was defined as the number of 
chronic diseases, including chronic non-specific lung disease, cardiac disease, peripheral 
arterial disease, stroke, diabetes mellitus, arthritis and malignancies. Depressive symptoms 
were assessed with the Dutch translation of the Centre for Epidemiologic Studies 
Depression Scale (CES-D), a 20-item self-report scale (ranging from 0 to 60) designed to 
measure depressive symptoms in the general population53. Physical activity was assessed 
by the LASA physical activity questionnaire54, a questionnaire in which frequency and 
duration of walking outside, cycling, light and heavy household activities and a maximum 
of two sports during the past two weeks are estimated. Scores were converted to total time 
spent on physical activities in hours per day. 
In the Leiden 85-plus Study, education was divided into low education level, including 
participants without schooling or primary school only, and high education level, equivalent 
to more than six years of schooling. Chronic diseases included chronic obstructive 
pulmonary disease, myocardial infarction, hypertension, stroke, diabetes mellitus, 
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rheumatoid arthritis, osteoarthrosis and malignancies15. Depressive symptoms were 
assessed by the 15-item Geriatric Depression Scale (GDS)55 and was restricted to 
participants with an MMSE score of 19 points or higher. Physical activity was measured 
with the Time Spending Pattern questionnaire, scoring on four items of physical exercise 
above routine daily physical activity56. Physical activity scores range from 0 to 16 points 
with lower scores indicating lower physical activity. 
Results 
Explanatory note by figure 3 
BCS in this figure can be interpreted as the unstandardized cross-lagged effect of each of the 
different cognitive domains on gait speed or handgrip strength. For example, BCS=0.01 m/s 
in the left upper panel for the age group of 85 – 90 years means that a 1 point lower MMSE 
score at time point n is associated with a 0.01 m/s steeper decline in gait speed at time point 
n+1 (which is for the Leiden 85-plus Study one year, but is in this figure recalculated to a 
three year cross-lagged effect to be comparable with LASA). 
Explanatory note by figure 4 
BSC in this figure can be interpreted as the unstandardized cross-lagged effect of gait speed 
or handgrip strength on each of the cognitive domains. For example, BSC=0.6 points in the 
left upper panel for the age group of 65 – 74 years means that a 1 m/s slower gait speed at 
time point n is associated with a 0.6 points steeper decline in MMSE score at time point 
n+1 (which is for LASA three years).  
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Human ageing is characterized by a gradual decline in cognitive and physical performance 
strongly determining someone’s functional abilities and quality of life. Insights into these 
age-related changes and most importantly their interactions might be suggestive for 
potential causal mechanisms, which is required for an effective clinical assessment, 
development and application of interventions. The aim of this thesis was to enhance this 
understanding by assessing the interactions of cognitive and physical performance across 
different groups of calendar and biological age, i.e. the person’s rate of ageing, which might 
deviate from its calendar age. Therefore, four different study populations were included: 
three large population based longitudinal cohorts and one cross-sectional study of elderly 
outpatients. The interactions were assessed across global measures representing functioning 
on several cognitive or physical domains and domain specific measures. Furthermore, the 
sensitivity of these measures to calendar and biological age were assessed. For the 
assessment of physical performance, instrumented measures were introduced to assess their 
additional value for the identification of age-related changes in physical performance and 
understanding of the influence of underlying determinants. 
Main findings 
In the chapters two and three we showed that the association of calendar age with domain 
specific measures of cognitive and physical performance is already observable from middle 
age, supporting the current literature1-4. Higher calendar age was associated with worse 
performances on memory and executive tasks, sit-to-stand transfers and steady-state 25-
meter walking speed. More complex cognitive tasks were sensitive for biological age, 
which was indicated by a better performance of offspring of nonagenarian siblings, who are 
enriched for familial factors of longevity, compared to their partners of similar calendar 
age. The assumed younger biological age of the offspring of nonagenarian siblings could 
not be detected by differences in physical performance. These findings indicate the early 
onset of age-related changes in cognitive and physical performance and the role cognitive 
performance might have in healthy ageing. 
Furthermore, we showed in chapter three that instrumented measures of physical 
performance have similar sensitivity to calendar age as standard clinical measures. 
Instrumented measured showed strongest associations with calendar age for physical tasks 
requiring a good balance control; the extension and flexion phase of sit-to-stand and stand-
to-sit transfers, respectively, and gait stability and symmetry in especially mediolateral 
direction during walking across a steady-state 25-meter course. These results indicate that 
instrumented measures can be used for the identification of age-related changes in physical 
performance from middle age and may be of additional value in getting insight into the 
influence of potential underlying determinants. 
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In the chapters four to six we showed that across two populations of different calendar and 
biological age, i.e. healthy middle-aged to older adults and elderly outpatients, a consistent 
cross-sectional relationship was found of poor global cognitive function and memory 
function with low 4-meter walking speed. For other physical domains such as standing 
balance and steady-state longer distance walks, associations were only found in the 
population of elderly outpatients. These findings suggest that independent of calendar and 
biological age, especially the initiation of movements, i.e. the start from standing position 
in the 4-meter walk, requires cognitive control, with memory function more in specific. 
Moreover, we showed in chapter four that the presence of cerebral microbleeds and 
lacunar infarcts, as potential common underlying determinant of cognitive and physical 
performance, was associated with lower steady-state 25-meter walking speed independent 
of cognitive performance at middle age. These findings suggest that the influence of brain 
structure and cognitive performance on physical performance are two independent 
processes and emphasize the clinical relevance of identifying each of these possible 
underlying determinants of physical performance in order to develop targeted therapies. 
In chapter seven, we showed that the temporal relationship between cognitive and physical 
performance differs across domains and calendar age, suggesting a specific rather than a 
general relationship. Across the age range of 55 to 90 years, lower executive function was 
associated with a stronger decline in 6-meter walking speed. From the age of 85 years, this 
relationship was found for the different measures of cognitive and physical performance 
that were tested, i.e. global cognitive function, memory and executive function, 6-meter 
walking speed and handgrip strength. An inverse relationship was found from the age of 65 
years, with lower 6-meter walking speed being associated with a stronger decline in global 
cognitive function and across all measures of cognitive performance in the age range of 75 
to 85 years. The findings in this study emphasize the importance of repeated measurements 
on different cognitive and physical domains and encourage further research to the 
development of domain and age specific interventions. 
Reflection 
Interactions between cognitive and physical performance 
According to the influence of calendar age, consistent interactions between cognitive and 
physical performance were found across the entire age range of 45 to 90 years covered by 
the four study populations that were included. The influence of cognitive performance on 
physical tasks was found from the age of 55 years, supporting the findings of functional 
imaging studies showing that already from middle age, several additional brain areas are 
recruited during the performance of physical tasks when compared to younger adults5,6. In 
the age range of 75 to 85 years, there seems to be a window with influences of physical 
performance on cognitive performance, while from the age of 85 years the influence of 
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cognitive performance is more prominent again with more elaborate interactions between 
different cognitive and physical domains compared to younger age groups. From the age of 
85 years, associations with both low and high complex tasks, i.e. handgrip strength and 
walking, respectively, were found, while in younger age groups only associations with high 
complex tasks were observed. These more consistent interactions between different 
cognitive and physical domains above the age of 75 years might indicate a more significant 
role of cognitive and physical performance as compensating mechanisms of each other. A 
possible explanation for that might be the deterioration of other underlying systems such as 
the central and peripheral nervous, musculoskeletal and cardiovascular system, which are 
likely to be more affected in higher age groups7,8. 
Our specific findings for calendar age on the temporal relationship between cognitive and 
physical performance in chapter seven, might explain the inconsistent results according to 
the direction of this relationship in the current literature. They support the findings of 
longitudinal studies on broad age ranges showing bidirectional relationships and the 
findings of unidirectional relationships of longitudinal studies including a specific age 
range9-12. The dependence of the interaction between cognitive and physical performance 
on specific domains, which was observed for both cross-sectional and temporal 
relationships, might explain the inconsistencies between studies even more. Furthermore, 
these findings indicate that different cognitive domains are incorporated in the performance 
of physical tasks instead of one in particular. Our results support the important role of 
executive function in walking, which has been frequently reported in literature, and also the 
less frequently studied influence of memory function13-15. Thereby, we showed that 
memory function might especially be of influence on the initiation of movements. 
However, future studies focusing on the role of different cognitive domains on these 
specific phases of physical tasks are needed to further explore this. 
With respect to the effect of biological age, the association of cognitive performance with 
both low and high complex physical tasks was also found for a clinically relevant 
population of elderly outpatients (mean age (standard deviation) 82 (7) years). In this 
population, poor global cognitive function was associated with a lower ability to maintain 
standing balance and 4-meter walking speed, representing physical tasks of low and high 
complexity, respectively. These findings underpin the idea of cognitive performance as 
compensating mechanism for the deterioration of several other underlying determinants of 
physical performance8,16. 
For the assessment of physical performance, we showed that instrumented measures can be 
used for the identification of age-related changes in physical performance from middle age 
and may be of additional value in getting insights into the influence of underlying 
determinants. In addition to our findings of standard clinical measures showing longer 
durations on the performances of sit-to-stand transfers and a steady-state 25-meter walk at 
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higher calendar age, the findings of instrumented measures suggested that this might 
especially be the influence of balance control as one of the underlying determinants of these 
tasks. These more refined observations of performances on physical tasks using 
instrumented measures might provide insights into the relation with specific cognitive 
domains as well. Some studies already showed that more specific instrumented measures of 
walking, instead of walking speed as standard clinical measure, are associated with 
particular cognitive domains such as executive function17,18. It was not possible to further 
explore this with the available data in this thesis, due to the minimal number of strides 
which is required for a reliable determination of instrumented measures of walking19. 
Within the study populations with available instrumented measures, only associations of 
cognitive performance with relatively short distance walks were found. This also shows a 
limitation of the use of instrumented measures, especially in clinical settings, where the 
practical realization of longer distance walks is sometimes difficult. More elaborate 
research on different and long enough physical tasks for a reliable estimation of 
instrumented measures across a wide range of calendar and biological age is needed to 
further investigate their additional value as sensitive marker of age-related changes and 
influence of underlying determinants in particular. 
Potential causal mechanisms 
One of the hypotheses for the co-occurrence of age-related changes in cognitive and 
physical performance is the presence of common underlying causes9,20. The findings in 
chapter seven showing that age-related changes in cognitive and physical performance are 
present in both directions at the same time, whereby the effect sizes were similar, support 
this hypothesis. Brain pathology, at least at middle age, as a common underlying cause is 
less likely due to the independence of the association between brain structure and physical 
performance on cognitive performance we showed in chapter four. However, longitudinal 
studies covering a broader age range and including repeated measures of brain structure are 
needed to get more insight into this. 
Besides brain pathology, other biological aspects of ageing have been suggested as 
common underlying causes of age-related changes in cognitive and physical performance. 
For example, an increased number of senescent cells, i.e. cells with a permanently arrested 
cell cycle, has been shown to be associated with age-related pathologies including decline 
in both cognitive and physical performance21. Furthermore, the potential role of 
metabolites, i.e. the intermediate and endpoint products of metabolism, in the ageing 
process has been shown by the age-dependence of metabolic profiles22,23. Differences 
according to these important indicators of biological age have been shown between 
offspring of nonagenarian siblings and their partners, indicating a younger biological age of 
the offspring24-26. The better cognitive performance which was found for the offspring of 
nonagenarian siblings compared to their partners in this thesis encourage the idea of the 
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potential role of these biological aspects as underlying causal mechanisms. Together with 
the findings of a bidirectional temporal relationship between cognitive and physical 
performance, the findings in this thesis emphasize the need for ongoing research on these 
more general aspects of ageing. 
Clinical implications and future directions 
The interactions between cognitive and physical performance shown in this thesis support 
the potential effectiveness of cognitive and physical interventions to delay physical and 
cognitive decline, respectively. Especially on the effectiveness of physical interventions 
several studies have been performed showing reduced risks on cognitive decline and 
dementia27-29. Because the relationship of baseline physical performance on cognitive 
performance was found in particular between 75 and 85 years, interventions might be most 
effective in this age range. In the age range of 85 to 90 years, future studies on the 
effectiveness of cognitive interventions may be interesting because of the more prominent 
role of cognitive performance indicated in this thesis. 
The already available interventions and promising results for the development of more 
specific ones encourages the early assessment of cognitive and physical performance. 
Based on the results in this thesis, we showed that age-related changes in cognitive and 
physical performance are already observable from middle age in the absence of overt 
diseases. Thereby, the presence of temporal relationships between cognitive and physical 
performance in each of the directions indicates the clinical relevance of measuring both; in 
patients with poor cognitive performance, a poor and faster change in physical performance 
should be considered and vice versa, in patients with poor physical performance a poor and 
faster change in cognitive performance should be considered. Because of the dependence of 
the interaction between cognitive and physical performance on specific domains, inclusion 
of these domain specific measures besides global measures is recommended. 
According to the assessment of physical performance, instrumented measures can be used 
for the identification of age-related changes and thereby showed promising results in giving 
additional insights into potential underlying determinants. Moreover, some instrumented 
measures have the advantage of enabling measurements outside clinical settings providing a 
more complete observation of the patient. Future studies are however needed to investigate 
the potential of instrumented measures in characterizing groups of individuals based on 
deterioration of specific underlying determinants, like deterioration of the sensory system 
(including vision and the vestibular and proprioceptive systems), low muscle mass or 
strength and cognitive impairment. This will enable the development of more refined and 
patient specific interventions.  
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Introductie 
Zelfredzaamheid van ouderen en daarmee ook de kwaliteit van leven wordt in belangrijke 
mate bepaald door zowel het cognitief als fysiek functioneren1,2. Bij het verouderen van de 
mens gaan het cognitief en fysiek functioneren geleidelijk achteruit3,4. Het doel van dit 
proefschrift was het inzicht in deze leeftijdsgerelateerde veranderingen in het cognitief en 
fysiek functioneren, en met name ook het inzicht in de interacties tussen beide, te vergroten. 
Dit met het uiteindelijke perspectief preventieve en therapeutische interventies te kunnen 
ontwikkelen die gericht zijn op een zo lang mogelijk behoud van de kwaliteit van leven. 
Het cognitief en fysiek functioneren en de interactie tussen beide is onderzocht binnen vier 
studiepopulaties van verschillende kalender- en biologische leeftijd. Hierbij is de 
biologische leeftijd een indicatie van de snelheid van het verouderingsproces. Deze leeftijd 
kan dus lager of hoger liggen dan de kalenderleeftijd – ook wel chronologische leeftijd 
genoemd –, die het daadwerkelijke aantal levensjaren weergeeft. Binnen elke populatie is 
naar globale en domeinspecifieke maten van het cognitief en fysiek functioneren gekeken, 
waarbij globale maten een weerspiegeling zijn van het functioneren over meerdere 
cognitieve dan wel fysieke domeinen. De gevoeligheid van deze maten voor kalender- en 
biologische leeftijd is onderzocht, alsook de interacties tussen deze cognitieve en fysieke 
maten. Voor het beoordelen van het fysiek functioneren is daarnaast voor een aantal 
domeinen gekeken naar de toegevoegde waarde van het gebruik van instrumentele maten – 
verkregen met bewegingssensoren – voor de identificatie van leeftijdsgerelateerde 
veranderingen en voor het mogelijk geven van inzicht in de invloed van onderliggende 
systemen. 
Studiepopulaties 
De Leiden Langleven Studie 
De Leiden Langleven Studie (LLS) is een longitudinaal cohort van 420 families bestaande 
uit minimaal twee langlevende broers en/of zussen van caucasische afkomst5. Mannen 
worden hierbij als langlevend beschouwd als zij 89 jaar of ouder zijn en vrouwen als zij 91 
jaar of ouder zijn. In dit proefschrift is cross-sectioneel onderzoek gedaan naar het cognitief 
en fysiek functioneren van de nakomelingen van deze langlevende broers en zussen en de 
partners van deze nakomelingen. In deze studiepopulatie zijn de nakomelingen en hun 
partners van vergelijkbare middelbare leeftijd (n=500, gemiddelde leeftijd 
(standaarddeviatie) 66 (6) jaar) en kunnen voor onderzoek verstorende omgevingsfactoren 
als gelijk worden beschouwd, doordat zij al gedurende lange tijd samenleven. Op basis van 
de resultaten van eerdere studies – waarin onder andere een lagere prevalentie van 
leeftijdsgerelateerde ziektebeelden van de nakomelingen ten opzichte van hun partners is 
gevonden – wordt verondersteld dat de biologische leeftijd van de nakomelingen lager is 
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dan die van hun partners6-9. Voor verschillende domeinspecifieke maten van het cognitief 
en fysiek functioneren is dan ook onderzocht wat naast de relatie met kalenderleeftijd de 
relatie met biologische leeftijd is, door het vergelijken van de nakomelingen uit de 
langlevende families met hun partners. Daarnaast is het cross-sectionele verband tussen de 
verschillende cognitieve en fysieke domeinen onderzocht en de relatie met mogelijke 
onderliggende breinschade. 
De Longitudinal Aging Study Amsterdam 
De Longitudinal Aging Study Amsterdam (LASA) is een longitudinaal cohort bestaande uit 
een willekeurige steekproef van deelnemers tussen de 55 en 85 jaar (n=3107, gemiddelde 
leeftijd (standaarddeviatie) 71 (9) jaar) uit drie verschillende regio’s in Nederland, die 
samen representatief zijn voor de Nederlandse bevolking10. Deze deelnemers worden elke 
drie jaar opnieuw onderzocht, waarbij ook het cognitief en fysiek functioneren wordt 
bepaald aan de hand van globale en domeinspecifieke maten. De data van de eerste vier 
herhaalde metingen zijn in dit proefschrift gebruikt om inzicht te krijgen in de relatie in de 
tijd – de temporele relatie – tussen het cognitief en fysiek functioneren; gaat een 
achteruitgang in het cognitief functioneren vooraf aan een achteruitgang in het fysiek 
functioneren, gaat deze relatie de andere kant op of komen de relaties in beide richtingen 
tegelijkertijd voor? Daarnaast is gekeken of deze relatie afhangt van het cognitieve en 
fysieke domein en van kalenderleeftijd. 
De Leiden 85-plus Studie 
De Leiden 85-plus Studie is een longitudinaal cohort van inwoners uit de stad Leiden 
(Nederland) met als inclusiecriterium het bereikt hebben van een leeftijd van 85 jaar in het 
jaar van inclusie11. Deze deelnemers (n=599) zijn jaarlijks gevolgd tot aan de leeftijd van 
90 jaar. Voor het bepalen van het cognitief en fysiek functioneren zijn vergelijkbare testen 
gebruikt als binnen LASA, waardoor samen met die studiepopulatie de relatie in de tijd 
over een leeftijdsrange van 55 tot 90 jaar is onderzocht. 
Poliklinische ouderen 
Om inzicht te krijgen in de mogelijke invloed van de gezondheidstoestand of biologische 
leeftijd op de interactie tussen het cognitief en fysiek functioneren, is cross-sectioneel 
onderzoek gedaan binnen een populatie van poliklinische ouderen. Deze studiepopulatie 
(n=299, gemiddelde leeftijd (standaarddeviatie) 82 (7) jaar) bestaat uit thuiswonende 
ouderen die werden verwezen naar het Behandeladviescentrum Ouderengeneeskunde van 
een middelgroot opleidingsziekenhuis (Bronovo ziekenhuis, Den Haag, Nederland) voor 
een uitgebreid geriatrisch onderzoek, het comprehensive geriatric assessement (CGA). 
Onderdeel van het CGA is de beoordeling van het cognitief en fysiek functioneren aan de 
hand van globale en domeinspecifieke maten.  
Chapter 9 
– 126 – 
Hoofdbevindingen 
In hoofdstuk 2 en 3 wordt beschreven dat het cross-sectionele verband tussen 
kalenderleeftijd en domeinspecifieke maten van het cognitief en fysiek functioneren al 
waarneembaar is vanaf middelbare leeftijd, wat in overeenstemming is met de huidige 
literatuur3,4,12,13. Deelnemers uit de LLS met een hogere kalenderleeftijd scoorden lager op 
geheugen- en executieve taken – uitvoerende taken die onder andere het vermogen om de 
aandacht te richten en de snelheid waarmee informatie verwerkt kan worden meten – en 
deden langer over het verrichten van vijf herhaalde bewegingen van zittende naar staande 
positie – de Chair Stand Test (CST) – en het afleggen van een 25-meter loop, gemeten op 
voorkeurssnelheid en in steady-state, dat wil zeggen zonder de versnellings- en 
vertragingsfase aan het begin en einde van looptest. De meest complexe cognitieve taken 
binnen zowel het geheugen als het executief functioneren waren daarbij ook gevoelig voor 
biologische leeftijdsverschillen, wat zichtbaar is door het verschil in prestaties tussen de 
nakomelingen uit langlevende families en hun partners. De nakomelingen scoorden hoger 
op deze complexe cognitieve taken vergeleken met hun partners (hoofdstuk 2). Dit verschil 
werd niet waargenomen voor het fysiek functioneren (hoofdstuk 3). De bevindingen in de 
hoofdstukken 2 en 3 benadrukken daarmee de vroege aanvang van leeftijdsgerelateerde 
veranderingen in het cognitief en fysiek functioneren en de rol die met name het cognitief 
functioneren zou kunnen hebben in succesvolle veroudering. 
In hoofdstuk 3 wordt daarnaast beschreven dat voor het detecteren van 
leeftijdsgerelateerde verschillende in het fysiek functioneren op middelbare leeftijd zowel 
standaard klinische als instrumentele maten kunnen worden gebruikt. Voorbeelden van 
standaard klinische maten zijn uitkomstmaten als de mogelijkheid om een test wel/niet 
succesvol te kunnen uitvoeren en de duur van een test. Onder instrumentele maten worden 
in dit hoofdstuk de uitkomstmaten bedoeld die zijn verkregen met een bewegingssensor 
gepositioneerd op de onderrug. Voor de eerder genoemde CST en 25-meter looptest was de 
effectgrootte van deze instrumentele maten voor het detecteren van leeftijdsgerelateerde 
verschillen gelijk aan die van de standaard klinische maten. De instrumentele maten die het 
sterkst geassocieerd waren met kalenderleeftijd hadden daarbij betrekking op de fasen die 
een goede controle van het evenwicht vereisen; de fase waarin de rug wordt gestrekt en 
gebogen gedurende de beweging van zittende naar staande positie en van staande naar 
zittende positie, respectievelijk, en de stabiliteit en symmetrie van het lopen in met name de 
zijwaartse richting. Deze resultaten tonen aan dat instrumentele maten gebruikt kunnen 
worden voor het detecteren van leeftijdsgerelateerde verschillen op middelbare leeftijd en 
daarnaast van toegevoegde waarde kunnen zijn in het verkrijgen van inzicht in de invloed 
van mogelijke onderliggende systemen. 
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In de hoofdstukken 4 tot en met 6 wordt de interactie tussen het cognitief en fysiek 
functioneren op cross-sectioneel niveau beschreven. Hierbij werd binnen twee 
verschillende studiepopulaties, de nakomelingen en partners uit de LLS en poliklinische 
ouderen, een consistent cross-sectioneel verband gevonden tussen het globaal cognitief 
functioneren, het geheugen en de 4-meter loopsnelheid, gemeten op voorkeurssnelheid en 
startend vanuit stand. Voor andere fysieke domeinen zoals het evenwicht in staande positie 
en het lopen over langere loopafstanden gemeten in steady-state conditie, werd alleen een 
verband gevonden met het cognitief functioneren binnen de poliklinische ouderen. Deze 
resultaten suggereren dat onafhankelijk van kalender- en biologische leeftijd, met name de 
initiatie van bewegingen – de start vanuit stand bij de 4-meter looptest – cognitieve 
aansturing vereist met het geheugen in het bijzonder. 
In hoofdstuk 4 is daarnaast gekeken naar het verband tussen verschillende maten van 
subklinische breinschade – breinschade die (nog) geen klinisch zichtbare symptomen geeft 
– en het cognitief en fysiek functioneren, om zicht te krijgen op de invloed van dit 
mogelijke (gemeenschappelijke) onderliggende mechanisme. Hierbij werd gevonden dat de 
aanwezigheid van kleine bloedingen en infarcten in de hersenen – cerebrale 
microbloedingen en lacunaire infarcten – geassocieerd is met een lagere loopsnelheid op de 
25-meter looptest, onafhankelijk van het cognitief functioneren. Deze bevindingen 
suggereren dat de invloed van deze subklinische vasculaire pathologie van het brein en het 
cognitief functioneren twee onafhankelijke mechanismen zijn die het fysiek functioneren 
beïnvloeden. Daarmee wordt tevens het klinische belang benadrukt van het identificeren 
van elk van deze mogelijke onderliggende systemen om tot doelgerichte behandelingen te 
kunnen komen. 
De bevindingen in hoofdstuk 7 beschrijven de relaties in de tijd tussen het cognitief en 
fysiek functioneren, waarbij werd gevonden dat deze relatie afhangt van het cognitieve en 
fysieke domein waarnaar wordt gekeken en de kalenderleeftijd. Over de gehele 
leeftijdsrange van 55 tot 90 jaar is een laag executief functioneren geassocieerd met een 
sterkere afname in de 6-meter loopsnelheid, gemeten op maximale snelheid en startend 
vanuit stand. Vanaf 85-jarige leeftijd werd deze relatie gevonden voor elk van de 
onderzochte cognitieve en fysieke maten: het globaal cognitief functioneren, het geheugen 
en executief functioneren, de 6-meter loopsnelheid en handknijpkracht. Vanaf 65-jarige 
leeftijd werd daarnaast een relatie in de andere richting gevonden: een lage 6-meter 
loopsnelheid is dan tevens geassocieerd met een sterkere afname in het globaal cognitief 
functioneren. In de leeftijdsrange van 75 tot 85 jaar gold dit voor alle cognitieve maten. De 
bevindingen van deze studie benadrukken het belang van het uitvoeren van herhaalde 
metingen over verschillende cognitieve en fysieke domeinen met toenemende leeftijd en 
onderschrijven daarnaast het belang van nader onderzoek naar de ontwikkeling van domein 
en leeftijdsspecifieke interventies. 
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Reflectie 
Interactie tussen het cognitief en fysiek functioneren 
De interactie tussen het cognitief en fysiek functioneren werd in dit proefschrift consistent 
aangetoond over de vier verschillende studiepopulaties die gezamenlijk een leeftijdsrange 
beslaan van 45 tot 90 jaar met variërende biologische leeftijd. De invloed van het cognitief 
functioneren op het fysiek functioneren werd daarbij gevonden vanaf een leeftijd van 55 
jaar. Deze bevindingen worden ondersteund door de bevindingen van functionele MRI 
studies – een speciale MRI-techniek waarmee de activiteit van de hersenen wordt gemeten 
–, waarin is aangetoond dat, in vergelijking met jongvolwassenen, reeds vanaf middelbare 
leeftijd verscheidene extra hersengebieden worden geactiveerd gedurende het uitvoeren van 
fysieke taken14,15. De leeftijdsrange van 75 tot 85 jaar lijkt een periode te zijn waarin er 
meer ruimte is voor invloed van het fysiek functioneren op het cognitief functioneren, 
terwijl vanaf 85-jarige leeftijd de invloed van het cognitief functioneren weer belangrijker 
lijkt te worden. Dit is onder meer zichtbaar door de verschillende cognitieve domeinen 
waarvoor een relatie in de tijd met het fysiek functioneren werden gevonden, in 
tegenstelling tot de bevindingen voor slechts één cognitief domein in jongere 
leeftijdsgroepen. Bovendien werden de interacties vanaf 85-jarige leeftijd gevonden voor 
zowel laag als hoog complexe taken – handknijpkracht en de 6-meter loopsnelheid, 
respectievelijk – terwijl in de leeftijdsrange van 55 tot 85 jaar dit verband alleen voor de 
hoog complexe taak werd gevonden. Het consistenter aanwezig zijn van de interacties 
tussen verschillende cognitieve en fysieke domeinen vanaf de leeftijd van 75 jaar zou erop 
kunnen wijzen dat het cognitief en fysiek functioneren twee belangrijke compenserende 
mechanismen voor elkaar zijn. Hieraan zou de verslechtering van onderliggende systemen 
zoals het centraal en perifeer zenuwstelsel, het musculoskeletaal systeem en het 
cardiovasculair systeem – die op hogere leeftijd meer zullen zijn aangetast16,17 – kunnen 
liggen. 
Deze kalenderspecifieke relatie in de tijd tussen het cognitief en fysiek functioneren zou 
een verklaring kunnen zijn voor de ogenschijnlijk tegenstrijdige resultaten wat betreft de 
richting van deze relatie in de huidige literatuur. De resultaten in dit proefschrift 
ondersteunen de bevindingen van longitudinale studies die een relatie in beide richtingen 
aantonen binnen studiepopulaties die een brede leeftijdsrange beslaan, alsook de 
bevindingen van longitudinale studies die een relatie in slechts één richting vinden binnen 
een specifieke leeftijdsgroep18-21. De afhankelijkheid van de interactie tussen het cognitief 
en fysiek functioneren van het specifieke domein dat is gemeten, wat in dit proefschrift 
binnen zowel het cross-sectioneel als longitudinaal onderzoek is waargenomen, zou de 
tegenstrijdige bevindingen nog verder kunnen verklaren. De resultaten bevestigen daarnaast 
de bevindingen van eerdere studies die wijzen op de betrokkenheid van meerdere 
cognitieve domeinen in het uitvoeren van fysieke taken in plaats van één in het bijzonder; 
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de frequent beschreven rol van het executief functioneren bij lopen werd ook in dit 
proefschrift gevonden, alsook de minder frequent aangetoonde invloed van het geheugen22-
24. Daarbij lijkt het geheugen met name van invloed op de initiatie van de beweging. Nader 
onderzoek is echter nodig om zicht te krijgen op deze meer specifieke relaties tussen 
cognitieve domeinen en de verschillende fasen waaruit een fysieke taak is opgebouwd. 
Wat betreft het effect van biologische leeftijd werd de interactie tussen het cognitief en 
fysiek functioneren tevens gevonden binnen de populatie van poliklinische ouderen. In deze 
populatie was een laag globaal cognitief functioneren geassocieerd met een kleinere 
mogelijkheid om het evenwicht te bewaren bij verschillende manieren van staan en de 4-
meter loopsnelheid, die respectievelijk een laag en hoog complexe taak representeren. Deze 
bevindingen onderbouwen de hypothese van het cognitief functioneren als compenserend 
mechanisme voor de verslechtering van verscheidene onderliggende systemen van het 
fysiek functioneren. 
Voor het fysiek functioneren werd gevonden dat instrumentele maten gebruikt kunnen 
worden voor het detecteren van verschillen op middelbare leeftijd en dat ze van 
toegevoegde waarde zouden kunnen zijn om inzicht te krijgen in de invloed van 
onderliggende systemen. In aanvulling op de resultaten verkregen met standaard klinische 
maten – die op hogere leeftijd een langere duur van de CST en 25-meter loop lieten zien –, 
lijkt op basis van de instrumentele maten met name de controle van het evenwicht een 
belangrijk onderliggend systeem te zijn. Deze meer verfijnde observatie van het fysiek 
functioneren door gebruik te maken van instrumentele maten zou wellicht ook inzicht 
kunnen geven in de relatie van het fysiek functioneren met specifieke cognitieve domeinen. 
Enkele studies hebben reeds specifieke relaties van instrumentele maten van het lopen met 
domeinspecifieke maten van het cognitief functioneren beschreven25,26. Wegens het 
minimaal aantal stappen dat nodig is voor een betrouwbare bepaling van instrumentele 
maten van het lopen, is het niet mogelijk geweest deze interactie met domeinspecifieke 
maten van het cognitief functioneren in dit proefschrift verder te onderzoeken27. Binnen de 
onderzochte studiepopulatie met beschikbare instrumentele maten zijn immers alleen 
interacties van het cognitief functioneren met de korte 4-meter loopafstand gevonden en 
niet met de langere 25-meter loopafstand. Dit toont tevens de beperking van het gebruik 
van instrumentele maten in klinische settingen aan, waarin het meten over langere 
loopafstanden soms lastig te realiseren is. Nader onderzoek naar het gebruik van 
instrumentele maten voor het beoordelen van verschillende fysieke domeinen, die zijn 
gemeten over een traject van voldoende lengte dan wel duur en over een breed spectrum 
wat betreft kalender- en biologische leeftijd, is dan ook nodig om de toegevoegde waarde 
hiervan als gevoelige marker voor leeftijdsgerelateerde verschillen verder te onderzoeken 
en zicht te krijgen op de relaties met specifieke cognitieve domeinen en op de invloed van 
mogelijke onderliggende systemen. 
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Mogelijke causale mechanismen 
Een van de mogelijke verklaringen voor het tegelijkertijd voorkomen van 
leeftijdsgerelateerde veranderingen in het cognitief en fysiek functioneren is de 
aanwezigheid van een gemeenschappelijke onderliggende oorzaak18,28. Deze hypothese 
wordt ondersteund door de bevindingen in hoofdstuk 7, waarin een bidirectionele interactie 
tussen het cognitief en fysiek functioneren werd gevonden met vergelijkbare effectgroottes 
in beide richtingen. Daarbij werd in hoofdstuk 4 gevonden dat subklinische vasculaire 
pathologie van het brein als gemeenschappelijke onderliggende oorzaak niet waarschijnlijk 
lijkt op middelbare leeftijd. Longitudinale studies met herhaalde metingen wat betreft de 
aanwezigheid van breinschade en het cognitief en fysiek functioneren, en die een bredere 
range beslaan wat betreft kalender- en biologisch leeftijd, zijn echter nodig om hier meer 
zicht op te krijgen. 
Naast breinschade zijn andere biologische processen van veroudering gesuggereerd als 
mogelijke gemeenschappelijke onderliggende oorzaak voor leeftijdsgerelateerde 
veranderingen in het cognitief en fysiek functioneren. Zo is aangetoond dat de 
aanwezigheid van een verhoogd aantal senescente cellen – zogenaamde verouderde cellen 
die niet meer delen, maar waarvan de stofwisseling nog wel (op een verlaagd niveau) actief 
is – geassocieerd is met verscheidene leeftijdsgerelateerde ziektebeelden, waaronder ook 
een verminderd cognitief en fysiek functioneren29. Daarnaast lijken metabolieten – de 
tussen- en eindproducten van de stofwisseling – een mogelijke rol te spelen in het 
verouderingsproces, wegens de leeftijdsafhankelijkheid van metabole profielen30,31. 
Verschillen met betrekking tot bovenstaande belangrijke indicatoren van biologische 
leeftijd zijn tevens aangetoond in de LLS tussen de nakomelingen uit langlevende families 
en hun partners7-9. Deze verschillen wijzen op een jongere biologische leeftijd van de 
nakomelingen uit de langlevende families ten opzichte van hun partners. De bevindingen in 
dit proefschrift die een beter cognitief functioneren van de nakomelingen laten zien, 
ondersteunen de hypothese van de mogelijke rol van deze biologische processen als 
onderliggend causaal mechanisme. Samen met de bevindingen van de bidirectionele relatie 
tussen het cognitief en fysiek functioneren, onderstrepen de resultaten in dit proefschrift de 
behoefte aan verdergaand onderzoek naar deze meer algemene aspecten van veroudering. 
Klinische implicaties en toekomstperspectieven 
De interacties tussen het cognitief en fysiek functioneren zoals beschreven in dit 
proefschrift onderschrijven de potentiële effectiviteit van zowel cognitieve als fysieke 
interventies om achteruitgang in respectievelijk het fysiek en cognitief functioneren te 
vertragen. Met name wat betreft de effectiviteit van fysieke interventies hebben 
verscheidene studies laten zien dat deze kunnen leiden tot een verlaagd risico op cognitieve 
achteruitgang en dementie32-34. Omdat de relatie in de tijd van het fysiek functioneren op 
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het cognitief functioneren met name werd gevonden in de leeftijd van 75 tot 85 jaar, zijn 
deze fysieke interventies mogelijk het meest effectief in deze leeftijdsrange. Nader 
onderzoek naar de effectiviteit van cognitieve interventies in de leeftijdsrange van 85 tot 
90-jarigen is van belang, vanwege de prominentere rol die het cognitief functioneren lijkt in 
te nemen vanaf deze leeftijd. 
Het reeds beschikbaar zijn van interventies en de stimulerende resultaten voor de 
ontwikkeling van domeinspecifieke en leeftijdsgerelateerde interventies, moedigen een 
vroege beoordeling van het cognitief en fysiek functioneren aan. In dit proefschrift hebben 
we laten zien dat leeftijdsrelateerde veranderingen in het cognitief en fysiek functioneren 
reeds zichtbaar zijn in een relatief gezonde populatie van middelbare leeftijd. De 
aanwezigheid van de relaties in de tijd tussen het cognitief en fysiek functioneren in beide 
richtingen benadrukt daarnaast het belang van het meten van beide aspecten; in patiënten 
met een laag cognitief functioneren dient rekening te worden gehouden met een verminderd 
en snellere achteruitgang in het fysiek functioneren en vice versa, in patiënten met een laag 
fysiek functioneren dient rekening te worden gehouden met een verminderd en snellere 
achteruitgang in het cognitief functioneren. Vanwege de afhankelijkheid van de interacties 
tussen het cognitief en fysiek functioneren van het specifieke domein, dienen bij de 
klinische beoordeling naast globale ook domeinspecifieke maten te worden meegenomen. 
Met betrekking tot de beoordeling van het fysiek functioneren kunnen instrumentele maten 
worden gebruikt voor het detecteren van leeftijdsgerelateerde verschillen. Daarnaast tonen 
deze maten verwachtingsvolle resultaten in het geven van inzicht in de invloed van 
mogelijke onderliggende systemen. Bovendien bieden instrumentele maten zoals verkregen 
met bewegingssensoren het voordeel dat zij het meten buiten de klinische setting mogelijk 
maken, wat een completere observatie van de patiënt geeft. Toekomstig onderzoek is echter 
nodig om zicht te krijgen op de mogelijkheid van het gebruik van instrumentele maten voor 
het karakteriseren van groepen van individuen op basis van de achteruitgang in specifieke 
onderliggende systemen, zoals een verslechtering van het sensorische systeem – die 
zintuigelijke informatie als zicht, evenwicht en tast omvat –, een lage spiermassa of 
spierkracht, dan wel cognitieve beperkingen. Dit zal uiteindelijk de ontwikkeling van meer 
verfijnde en patiëntspecifieke interventies mogelijk maken.  
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